AB 246: Product safety: menstrual products: perfluoroalkyl and polyfluoroalkyl substances.
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2023-09-12
Current Status:
Failed
(2024-02-01: Consideration of Governor's veto stricken from file.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
Existing law prohibits, beginning January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. Existing law similarly prohibits, beginning January 1, 2025, any person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously owned, textile articles that contain regulated PFAS, except as specified, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with these provisions.
This bill would, beginning January 1, 2025, similarly prohibit any person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in menstrual products to comply with these provisions. The bill would require a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with these provisions and does not contain any regulated PFAS. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $10,000 per day for each violation, as specified, and would authorize the Attorney General, a city prosecutor, a city or county attorney, a county counsel, or a district attorney to bring an action to enforce these provisions.
Existing law prohibits, beginning January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. Existing law similarly prohibits, beginning January 1, 2025, any person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously owned, textile articles that contain regulated PFAS, except as specified, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with these provisions.
This bill would, beginning January 1, 2025, similarly prohibit any person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in menstrual products to comply with these provisions. The bill would require a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with these provisions and does not contain any regulated PFAS. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $10,000 per day for each violation, as specified, and would authorize the Attorney General, a city prosecutor, a city or county attorney, a county counsel, or a district attorney to bring an action to enforce these provisions.
Existing law prohibits, beginning January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. Existing law similarly prohibits, beginning January 1, 2025, any person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously owned, textile articles that contain regulated PFAS, except as specified, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with these provisions.
This bill would, beginning January 1, 2025, similarly prohibit any person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in menstrual products to comply with these provisions. The bill would require a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with these provisions and does not contain any regulated PFAS. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $5,000 for a first violation and not to exceed $10,000 per day for each subsequent violation, upon an action brought by as specified, and would authorize the Attorney General, a city attorney, a county counsel, or a district attorney. attorney to bring an action to enforce these provisions.
Existing law prohibits, beginning January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. Existing law similarly prohibits, beginning January 1, 2025, any person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously owned, textile articles that contain regulated PFAS, except as specified, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with these provisions.
This bill would, beginning January 1, 2025, similarly prohibit any person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in menstrual products to comply with these provisions. The bill would require a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with these provisions and does not contain any regulated PFAS. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $5,000 for a first violation and not to exceed $10,000 for each subsequent violation, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney.
Existing law prohibits, beginning January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. Existing law similarly prohibits, beginning January 1, 2025, any person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously owned, textile articles that contain regulated PFAS, except as specified, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with these provisions.
This bill would, beginning January 1, 2025, similarly prohibit any person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in menstrual products to comply with these provisions. The bill would require a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with these provisions and does not contain any regulated PFAS.
Existing law prohibits, beginning January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. Existing law similarly prohibits, beginning January 1, 2025, any person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously owned, textile articles that contain regulated PFAS, except as specified, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with these provisions.
This bill would, beginning January 1, 2025, similarly prohibit any person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in menstrual products to comply with these provisions. The bill would require a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with these provisions and does not contain any regulated PFAS.
Existing law, the Sherman Food, Drug, and Cosmetic Law, requires a package or box containing menstrual products that was manufactured on or after January 1, 2023, for sale or distribution in this state to have printed on the label a plain and conspicuous list of all ingredients, as defined, in the product, by weight, and prohibits the sale of a menstrual product in the state unless the menstrual product and the manufacturer of the menstrual product comply with the specified labeling requirements.Existing law, beginning January 1, 2025, prohibits a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined.This bill would state the intent of the Legislature to enact legislation to eliminate PFAS from menstrual products.Existing law, the Sherman Food, Drug, and Cosmetic Law, requires a package or box containing menstrual products that was manufactured on or after January 1, 2023, for sale or distribution in this state to have printed on the label a plain and conspicuous list of all ingredients, as defined, in the product, by weight, and prohibits the sale of a menstrual product in the state unless the menstrual product and the manufacturer of the menstrual product comply with the specified labeling requirements.
Existing law, beginning January 1, 2025, prohibits a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined.
This bill would state the intent of the Legislature to enact legislation to eliminate PFAS from menstrual products.
(a)The Legislature finds and declares all of the following:
(1)Perfluoroalkyl and polyfluoroalkyl substances, or PFAS, are persistent, toxic, and bioaccumulative substances with multiple adverse effects on human health.
(2)PFAS are utilized in a broad range of products for their water- and stain-resistant properties, including clothing and textiles, despite the growing body of evidence that these materials may leach into food, water supplies, and even the human body through prolonged exposure.
(3)Adverse health impacts associated with PFAS include kidney and liver damage, decreased immune system function, interference with vaccine uptake, developmental and reproductive harm, increased risk of asthma, and increased incidences of testicular and kidney cancer for those with high exposure.
(4)Multiple alternatives to PFAS have been identified for water resistance in menstrual products and textiles. For addressing stains, soap and water work well for most situations, and alternative materials and cleaning solutions offer additional options.
(b)Therefore, it is the intent of the Legislature, in enacting this act, to phase out the use of PFAS in menstrual products.
SEC. 2.Chapter 14.5 (commencing with Section 108985) is added to Part 3 of Division 104 of the Health and Safety Code, to read:14.5.Menstrual Products108985.For purposes of this chapter, the following terms have the following definitions:
(a)Manufacturer has the same meaning as that term is defined in Section 108952.
(b)Menstrual product means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)Perfluoroalkyl and polyfluoroalkyl substances or PFAS means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS means either of the following:
(1)PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
(2)Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million, as measured in total organic fluorine.
108986.(a)Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b)A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c)A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d)A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
(e)(1)A person or entity who violates this section is liable for a civil penalty not to exceed ten thousand dollars ($10,000) per day for each violation. That civil penalty may be assessed and recovered in a civil action brought in any court of competent jurisdiction.
(2)In assessing the amount of a civil penalty for a violation of this chapter, the court shall consider all of the following:
(A)The nature and extent of the violation.
(B)The number of, and severity of, the violations.
(C)The economic effect of the penalty on the violator.
(D)Whether the violator took good faith measures to comply with this chapter and when these measures were taken.
(E)The deterrent effect that the imposition of the penalty would have on both the violator and the regulated community as a whole.
(F)Whether there were contributing environmental factors about which a reasonable person knew or should have known.
(f)Actions pursuant to this section may be brought by the Attorney General in the name of the people of the state, by a district attorney, by a city or county attorney, by a county counsel, or by a city prosecutor.
(g)Civil penalties collected pursuant to this section shall be paid to the office of the city or county attorney, city prosecutor, county counsel, district attorney, or Attorney General, whichever office brought the action.
(h)This section does not impair or impede any other rights, causes of action, claims, or defenses available under any other law. The remedies provided in this section are cumulative with any other remedies available under any other law.
(a)The Legislature finds and declares all of the following:
(1)Perfluoroalkyl and polyfluoroalkyl substances, or PFAS, are persistent, toxic, and bioaccumulative substances with multiple adverse effects on human health.
(2)PFAS are utilized in a broad range of products for their water- and stain-resistant properties, including clothing and textiles, despite the growing body of evidence that these materials may leach into food, water supplies, and even the human body through prolonged exposure.
(3)Adverse health impacts associated with PFAS include kidney and liver damage, decreased immune system function, interference with vaccine uptake, developmental and reproductive harm, increased risk of asthma, and increased incidences of testicular and kidney cancer for those with high exposure.
(4)Multiple alternatives to PFAS have been identified for water resistance in menstrual products and textiles. For addressing stains, soap and water work well for most situations, and alternative materials and cleaning solutions offer additional options.
(b)Therefore, it is the intent of the Legislature, in enacting this act, to phase out the use of PFAS in menstrual products.
SEC. 2.Chapter 14.5 (commencing with Section 108985) is added to Part 3 of Division 104 of the Health and Safety Code, to read:14.5.Menstrual Products108985.For purposes of this chapter, the following terms have the following definitions:
(a)Manufacturer has the same meaning as that term is defined in Section 108952.
(b)Menstrual product means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)Perfluoroalkyl and polyfluoroalkyl substances or PFAS means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS means either of the following:
(1)PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
(2)Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million, as measured in total organic fluorine.
108986.(a)Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b)A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c)A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d)A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
(e)(1)A person or entity that violates this section shall be liable for a civil penalty not to exceed ten thousand dollars ($10,000) per day for each violation. The civil penalties under this subdivision shall begin accruing on the date an action is brought pursuant to paragraph (2).(2)An action to enforce this section may be brought by the Attorney General, a city attorney, a county counsel, or a district attorney in a court of competent jurisdiction.(3)For purposes of this section, a violation is deemed to have occurred upon the manufacture, distribution, sale, or offer for sale, as applicable, of a menstrual product in violation of this section. Menstrual products that belong to the same stock keeping unit (SKU) as the menstrual product in violation of this section and manufactured, distributed, sold, or offered for sale, as applicable, prior to an action brought under paragraph (2) are considered part of the same, single violation.(e)(1)A person or entity who violates this section is liable for a civil penalty not to exceed ten thousand dollars ($10,000) per day for each violation. That civil penalty may be assessed and recovered in a civil action brought in any court of competent jurisdiction.
(2)In assessing the amount of a civil penalty for a violation of this chapter, the court shall consider all of the following:
(A)The nature and extent of the violation.
(B)The number of, and severity of, the violations.
(C)The economic effect of the penalty on the violator.
(D)Whether the violator took good faith measures to comply with this chapter and when these measures were taken.
(E)The deterrent effect that the imposition of the penalty would have on both the violator and the regulated community as a whole.
(F)Whether there were contributing environmental factors about which a reasonable person knew or should have known.
(f)Actions pursuant to this section may be brought by the Attorney General in the name of the people of the state, by a district attorney, by a city or county attorney, by a county counsel, or by a city prosecutor.
(g)Civil penalties collected pursuant to this section shall be paid to the office of the city or county attorney, city prosecutor, county counsel, district attorney, or Attorney General, whichever office brought the action.
(f)(h)This section does not impair or impede any other rights, causes of action, claims, or defenses available under any other law. The remedies provided in this section are cumulative with any other remedies available under any other law.
(a)The Legislature finds and declares all of the following:
(1)Perfluoroalkyl and polyfluoroalkyl substances, or PFAS, are persistent, toxic, and bioaccumulative substances with multiple adverse effects on human health.
(2)PFAS are utilized in a broad range of products for their water- and stain-resistant properties, including clothing and textiles, despite the growing body of evidence that these materials may leach into food, water supplies, and even the human body through prolonged exposure.
(3)Adverse health impacts associated with PFAS include kidney and liver damage, decreased immune system function, interference with vaccine uptake, developmental and reproductive harm, increased risk of asthma, and increased incidences of testicular and kidney cancer for those with high exposure.
(4)Multiple alternatives to PFAS have been identified for water resistance in menstrual products and textiles. For addressing stains, soap and water work well for most situations, and alternative materials and cleaning solutions offer additional options.
(b)Therefore, it is the intent of the Legislature, in enacting this act, to phase out the use of PFAS in menstrual products.
SEC. 2.Chapter 14.5 (commencing with Section 108985) is added to Part 3 of Division 104 of the Health and Safety Code, to read:14.5.Menstrual Products108985.For purposes of this chapter, the following terms have the following definitions:
(a)Manufacturer has the same meaning as that term is defined in Section 108952.
(b)Menstrual product means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)Perfluoroalkyl and polyfluoroalkyl substances or PFAS means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS means either of the following:
(1)PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
(2)Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million, as measured in total organic fluorine.
108986.(a)Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b)A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c)A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d)A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
(e)(1)Upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a A person or entity that violates this section shall be liable for a civil penalty not to exceed five thousand dollars ($5,000) for a first violation, and not to exceed ten thousand dollars ($10,000) per day for each subsequent violation. The civil penalties under this subdivision shall begin accruing on the date an action is brought pursuant to paragraph (2).
(2)An action to enforce this section may be brought by the Attorney General, a city attorney, a county counsel, or a district attorney in a court of competent jurisdiction.
(3)For purposes of this section, a violation is deemed to have occurred upon the manufacture, distribution, sale, or offer for sale, as applicable, of a menstrual product in violation of this section. Menstrual products that belong to the same stock keeping unit (SKU) as the menstrual product in violation of this section and manufactured, distributed, sold, or offered for sale, as applicable, prior to an action brought under paragraph (2) are considered part of the same, single violation.
(2)(f)This section does not impair or impede any other rights, causes of action, claims, or defenses available under any other law. The remedies provided in this section are cumulative with any other remedies available under any other law.
(a)The Legislature finds and declares all of the following:
(1)Perfluoroalkyl and polyfluoroalkyl substances, or PFAS, are persistent, toxic, and bioaccumulative substances with multiple adverse effects on human health.
(2)PFAS are utilized in a broad range of products for their water- and stain-resistant properties, including clothing and textiles, despite the growing body of evidence that these materials may leach into food, water supplies, and even the human body through prolonged exposure.
(3)Adverse health impacts associated with PFAS include kidney and liver damage, decreased immune system function, interference with vaccine uptake, developmental and reproductive harm, increased risk of asthma, and increased incidences of testicular and kidney cancer for those with high exposure.
(4)Multiple alternatives to PFAS have been identified for water resistance in menstrual products and textiles. For addressing stains, soap and water work well for most situations, and alternative materials and cleaning solutions offer additional options.
(b)Therefore, it is the intent of the Legislature, in enacting this act, to phase out the use of PFAS in menstrual products.
SEC. 2.Chapter 14.5 (commencing with Section 108985) is added to Part 3 of Division 104 of the Health and Safety Code, to read:14.5.Menstrual Products108985.For purposes of this chapter, the following terms have the following definitions:
(a)Manufacturer has the same meaning as that term is defined in Section 108952.
(b)Menstrual product means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)Perfluoroalkyl and polyfluoroalkyl substances or PFAS means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS means either of the following:
(1)PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
(2)Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million, as measured in total organic fluorine.
108986.(a)Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b)A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c)A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d)A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
(e)(1)Upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a person or entity that violates this section shall be liable for a civil penalty not to exceed five thousand dollars ($5,000) for a first violation, and not to exceed ten thousand dollars ($10,000) for each subsequent violation.
(2)This section does not impair or impede any other rights, causes of action, claims, or defenses available under any other law. The remedies provided in this section are cumulative with any other remedies available under any other law.
(a)The Legislature finds and declares all of the following:
(1)Perfluoroalkyl and polyfluoroalkyl substances, or PFAS, are persistent, toxic, and bioaccumulative substances with multiple adverse effects on human health.
(2)PFAS are utilized in a broad range of products for their water- and stain-resistant properties, including clothing and textiles, despite the growing body of evidence that these materials may leach into food, water supplies, and even the human body through prolonged exposure.
(3)Adverse health impacts associated with PFAS include kidney and liver damage, decreased immune system function, interference with vaccine uptake, developmental and reproductive harm, increased risk of asthma, and increased incidences of testicular and kidney cancer for those with high exposure.
(4)Multiple alternatives to PFAS have been identified for water resistance in menstrual products and textiles. For addressing stains, soap and water work well for most situations, and alternative materials and cleaning solutions offer additional options.
(b)Therefore, it is the intent of the Legislature, in enacting this act, to phase out the use of PFAS in menstrual products.
SEC. 2.Chapter 14.5 (commencing with Section 108985) is added to Part 3 of Division 104 of the Health and Safety Code, to read:14.5.Menstrual Products108985.For purposes of this chapter, the following terms have the following definitions:
(a)Manufacturer has the same meaning as that term is defined in Section 108952.
(b)Menstrual product means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)Perfluoroalkyl and polyfluoroalkyl substances or PFAS means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS means PFAS either of the following:
(1)PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
(2)Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million, as measured in total organic fluorine.
108986.(a)Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b)A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c)A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d)A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
(a)The Legislature finds and declares all of the following:
(1)Perfluoroalkyl and polyfluoroalkyl substances, or PFAS, are persistent, toxic, and bioaccumulative substances with multiple adverse effects on human health.
(2)PFAS are utilized in a broad range of products for their water- and stain-resistant properties, including clothing and textiles, despite the growing body of evidence that these materials may leach into food, water supplies, and even the human body through prolonged exposure.
(3)Adverse health impacts associated with PFAS include kidney and liver damage, decreased immune system function, interference with vaccine uptake, developmental and reproductive harm, increased risk of asthma, and increased incidences of testicular and kidney cancer for those with high exposure.
(4)Multiple alternatives to PFAS have been identified for water resistance in menstrual products and textiles. For addressing stains, soap and water work well for most situations, and alternative materials and cleaning solutions offer additional options.
(b)Therefore, it is the intent of the Legislature, in enacting this act, to phase out the use of PFAS in menstrual products.
SEC. 2.Chapter 14.5 (commencing with Section 108985) is added to Part 3 of Division 104 of the Health and Safety Code, to read:14.5.Menstrual Products108985.For purposes of this chapter, the following terms have the following definitions:
(a)Manufacturer has the same meaning as that term is defined in Section 108952.
(b)Menstrual product means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)Perfluoroalkyl and polyfluoroalkyl substances or PFAS means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS means PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
108986.(a)Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b)A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c)A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d)A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
SECTION 1.It is the intent of the Legislature to enact legislation to eliminate perfluoroalkyl and polyfluoroalkyl substances (PFAS) from menstrual products.It is the intent of the Legislature to enact legislation to eliminate perfluoroalkyl and polyfluoroalkyl substances (PFAS) from menstrual products.
|
Date
|
Status
|
|---|---|
| Feb 1, 2024 | Consideration of Governor's veto stricken from file. |
| Jan 3, 2024 | Consideration of Governor's veto pending. |
| Oct 8, 2023 | Vetoed by Governor. |
| Sep 15, 2023 | Enrolled and presented to the Governor at 4 p.m. |
| Sep 11, 2023 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 71. Noes 0. Page 3173.). |
| Sep 7, 2023 | Assembly Rule 77 suspended. (Page 3011.) |
| Sep 6, 2023 | In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 8 pursuant to Assembly Rule 77. |
| Sep 6, 2023 | Read third time. Passed. Ordered to the Assembly. (Ayes 34. Noes 0. Page 2416.). |
| Sep 5, 2023 | Read second time. Ordered to third reading. |
| Sep 1, 2023 | Read third time and amended. Ordered to second reading. |
| Aug 15, 2023 | Read second time. Ordered to third reading. |
| Aug 14, 2023 | From committee: Be ordered to second reading pursuant to Senate Rule 28.8. |
| Jul 10, 2023 | Read second time and amended. Re-referred to Com. on APPR. |
| Jul 6, 2023 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 10. Noes 0.) (July 6). |
| Jun 21, 2023 | From committee: Do pass and re-refer to Com. on JUD. (Ayes 5. Noes 0.) (June 21). Re-referred to Com. on JUD. |
| May 24, 2023 | Referred to Coms. on E.Q. and JUD. |
| May 16, 2023 | In Senate. Read first time. To Com. on RLS. for assignment. |
| May 15, 2023 | Read third time. Passed. Ordered to the Senate. (Ayes 70. Noes 0. Page 1551.) |
| May 4, 2023 | Read second time. Ordered to third reading. |
| May 3, 2023 | From committee: Do pass. (Ayes 14. Noes 0.) (May 3). |
| Apr 19, 2023 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (April 18). Re-referred to Com. on APPR. |
| Apr 17, 2023 | Re-referred to Com. on E.S. & T.M. |
| Apr 12, 2023 | From committee chair, with author's amendments: Amend, and re-refer to Com. on E.S. & T.M. Read second time and amended. |
| Apr 11, 2023 | Re-referred to Com. on E.S. & T.M. |
| Apr 10, 2023 | From committee chair, with author's amendments: Amend, and re-refer to Com. on E.S. & T.M. Read second time and amended. |
| Mar 13, 2023 | Re-referred to Com. on E.S. & T.M. |
| Mar 9, 2023 | Referred to Com. on E.S. & T.M. |
| Mar 9, 2023 | From committee chair, with author's amendments: Amend, and re-refer to Com. on E.S. & T.M. Read second time and amended. |
| Jan 18, 2023 | From printer. May be heard in committee February 17. |
| Jan 17, 2023 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 11, 2023 | AB 246 Papan Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Sep 6, 2023 | Assembly 3rd Reading AB246 Papan et al. By Skinner | Senate Floor |
Passed |
|
| Jul 6, 2023 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Judiciary |
Passed |
|
| Jun 21, 2023 | Do pass, but first be re-referred to the Committee on [Judiciary] | Senate Standing Committee on Environmental Quality |
Passed |
|
| May 15, 2023 | AB 246 Papan Assembly Third Reading | Assembly Floor |
Passed |
|
| May 3, 2023 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 18, 2023 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Environmental Safety and Toxic Materials |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| American Chemistry Council | ** Against | |
| American College Of Obstetricians And Gynecologists District Ix | ** Support | |
| American Forest & Paper Association | ** Against | |
| A Voice for Choice Advocacy | ** Support | |
| Breast Cancer Prevention Partners | ** Support | |
| California Association Of Sanitation Agencies | ** Support | |
| California Legislative Women's Caucus | ** Support | |
| California Manufacturers And Technology Association | ** Against | |
| Californians Against Waste | ** Support | |
| California Professional Firefighters | ** Support | |
| california water service | ** Support | |
| CALPIRG | ** Support | |
| Center for Baby and Adult Hygiene Products | ** Against | |
| Center For Public Environmental Oversight | ** Support | |
| City of Camarillo | ** Support | |
| cleanearth4kids.org | ** Support | |
| Clean Seas Lobbying Coalition | ** Support | |
| Clean Water Action | ** Support | |
| Consumer Healthcare Products Association | ** Against | |
| Environmental Working Group | ** Support | |
| Green Science Policy Institute | ** Support | |
| Irvine Ranch Water District | ** Support | |
| Los Angeles County Sanitation Districts | ** Support | |
| NARAL Pro-Choice California | ** Support | |
| National Stewardship Action Council | ** Support | |
| Natural Resources Defense Council | ** Support | |
| Orange County Sanitation District | ** Support | |
| Republic Services - Western Region | ** Support | |
| Responsible Purchasing Network | ** Support | |
| San Diego County Water Authority | ** Support | |
| Sierra Club California | ** Support | |
| Silicon Valley Youth Climate Action | ** Support | |
| Solano County Democratic Central Committee | ** Support | |
| Weideman Group | ** Support | |
| Women's Voices for the Earth | ** Support | |
| Yorba Linda Water District | ** Support |
GOVERNOR'S VETO
GV Bill Id:AB 246
Author:(Papan)
As Enrolled Ver:September 12, 2023
2/3 vote
SUMMARY
Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances (PFAS).
The Senate Amendments:
- Delete the provisions in the bill that authorized the Attorney General (AG), a city attorney, a county counsel, or a district attorney to levy a civil penalty not to exceed $5,000 for a first violation and not to exceed $10,000 for each subsequent violation.
- Authorize, instead of the provisions above, the AG in the name of the people of the state, a district attorney, a city or county attorney, a county counsel, or a city prosecutor to bring actions pursuant to the provisions of the bill.
- Provide that a person or entity who violates the provisions of the bill is liable for a civil penalty not to exceed $10,000 per day for each violation.
- Provide that the civil penalty may be assessed and recovered in a civil action brought in any court of competent jurisdiction.
- Require, in assessing the amount of a civil penalty for a violation of the provisions of this bill, the court to consider all of the following:
- The nature and extent of the violation;
- The number of, and severity of, the violation;
- The economic effect of the penalty on the violator;
- Whether the violator took good faith measures to comply with the provisions of this bill and when these measures were taken;
- The deterrent effect that the imposition of the penalty would have on both the violator and the regulated community as a whole; and,
- Whether there were contributing environmental factors about which a reasonable person knew or should have known.
- Require that civil penalties collected pursuant to the provisions of this bill be paid to the office of the city or county attorney, city prosecutor, county counsel, district attorney, or AG, whichever office brought the action.
Governor’s Veto Message
This bill would prohibit, by 2025, the manufacture, distribution, or sale of menstrual products that contain intentionally added perfluoroalkyl or polyfluoroalkyl substances (PFAS) at a certain concentration level, as well as limit, by 2027, the concentration of total organic fluorine in menstrual products.
This is one of three single-product chemical bans passed by the Legislature this year that attempt to address serious concerns with the presence of PFAS in consumer products. These bills do not identify or require any regulatory agency to determine compliance with, or enforce, the proposed statute.
While I strongly support the author's intent and have signed similar legislation in the past, I am concerned that this bill falls short of providing enhanced protection to California consumers due to lack of regulatory oversight. Previously enacted single-product chemical bans, which also lack oversight, are proving challenging to im.plement, with inconsistent interpretations and confusion among manufacturers about how to comply with the restrictions.
In order to instill consumer confidence and effectively address public health and environmental concerns, I am directing the Department of Toxic Substances Control to engage with the author and the Legislature and consider alternative approaches to regulating the use of these harmful chemicals in consumer products.
COMMENTS
Perfluoroalkyl and polyfluoroalkyl substances (PFAS): Per- and polyfluorinated substances (PFASs) are a large group of synthetic, highly fluorinated substances that have been widely used in industrial and consumer applications for their heat, water, and lipid resistance properties for more than seven decades. PFAS are long-lasting chemicals that break down very slowly over time. PFAS are ubiquitous, and researchers have found PFAS in indoor and outdoor environments, plants, soil, food, drinking water, wildlife, companion animals, production animals, and humans at locations across the nation and around the globe. Scientific studies have shown that exposure to some PFAS may be linked to harmful health effects in humans and animals. More than 9,000 PFAS chemicals are included in the United States Environmental Protection Agency's (US EPA's) Master List of PFAS Substances.
Exposure to PFAS: The main route of exposure to PFAS is through ingestion of contaminated food or liquid (accounting for up to half of total exposure), and through inhalation and ingestion of contaminated indoor air and dust. Food can become contaminated with PFAS through contaminated soil and water used to grow the food, food packaging containing PFAS, and equipment that uses PFAS during food processing. Some foods, such as fish, meat, eggs and leafy vegetables, may contain PFAS due to bioaccumulation and crop uptake. Studies have shown that PFAS can transfer from pregnant mothers to their fetuses via the placenta during gestation, as well as transfer from nursing mothers to their infants via breastfeeding. Dermal exposure is also possible when people touch products treated with PFAS, such as carpets or clothing. Young children may be susceptible to higher levels of exposure than adults because they ingest more dust containing PFAS and mouth PFAS-treated consumer products. Workers, such as carpet installers, carpet cleaners, firefighters, and workers in furniture, furnishings, outdoor clothing, and carpet stores, may also experience above average PFAS exposure levels.
Exposure to PFAS in drinking water is an escalating concern due to the persistence of PFAS chemicals in the environment and their tendency to accumulate in groundwater.
Hazard traits of PFAS: An intrinsic property of PFAS is the extreme environmental persistence of either the individual compounds or their degradation products or both, resulting in their classification as "forever chemicals." Most PFAS are mobile in environmental media such as air and water, and thus are widespread in living organisms and the environment. Several PFAS bioaccumulate significantly in animals or plants and emerging evidence points to their phytotoxicity, aquatic toxicity, and terrestrial ecotoxicity.
According to the US EPA, current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to: reproductive effects such as decreased fertility or increased high blood pressure in pregnant women; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body’s immune system to fight infections, including reduced vaccine response; interference with the body’s natural hormones; and, increased cholesterol levels and/or risk of obesity.
Regulating PFAS as a class: The Department of Toxic Substances Control has adopted a rationale for regulating PFAS chemicals as a class, concluding, "it is both ineffective and impractical to regulate this complex class of chemicals with a piecemeal approach." This rationale was presented in the February, 2021, Environmental Health Perspectives article, "Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program," which states, "The widespread use, large number, and diverse chemical structures of PFAS pose challenges to any sufficiently protective regulation, emissions reduction, and remediation at contaminated sites. Regulating only a subset of PFAS has led to their replacement with other members of the class with similar hazards, that is, regrettable substitutions… Regulating PFAS as a class is thus logical, necessary, and forward-thinking."
PFAS in menstrual products: In the United States, approximately 72.7 million women are of reproductive age (15 - 49). During the reproductive stage of their lives, people who menstruate rely on a diverse range of menstrual products, from tampons to pads to menstrual cups to period underwear. To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. Conducted at US EPA-certified laboratories between 2020 and 2022, the tests detected organic fluorine, a marker for PFAS, in several menstrual products. For example, 22% of the 23 tampon products tested had indications of PFAS, including two products advertised as "organic." Forty eight percent of 46 different sanitary pads, panty liners, and incontinence pads tested had indications of PFAS, including several products marketed as "organic" and "natural." Sixty-five percent of period underwear products tested, and 57% of the period underwear brands tested, had detectable levels of fluorine present. Exposure to PFAS through menstrual products is particularly concerning because the vagina is an extremely vascular area and dermal exposure in the vaginal area is often higher than other places of the body. Additionally, people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.
This bill: This bill prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS.
Enforcement: Like this bill, most of the state's chemical prohibition bills were placed in what is sometimes referred to as the "orphan codes." In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no compliance program, no guidance for manufacturers seeking to comply with these laws, no related information for consumers, and no state entity investigating complaints, testing products for compliance, or bringing enforcement actions against violators.
This bill: This bill provides the AG and other government attorneys with the authority to levy a civil penalty, as specified, not to exceed $10,000 per day for each violation of the provisions of the bill. These penalty provisions are in addition to the AG's existing authority to enforce this, and related product safety statutory provisions, such as through the Unfair Competition Law.
According to the Author
"These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAS in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
AB 246 takes a critical step towards protecting women’s health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California’s pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women's health must be prioritized over the use of these unnecessary chemicals. It's past time to protect women and our environment."
Arguments in Support
California Water Service (Cal Water) argues in support of this bill, "Each year, we invest hundreds of millions of dollars into our water systems to ensure we continue to deliver a reliable supply of high-quality drinking water. We continue monitoring our water sources for PFAS and are taking action where needed. From removing water supply sources from service to constructing new water treatment facilities, Cal Water has worked diligently to ensure the safety of the drinking water we provide to our customers… In the coming years, substantial amounts of money will be spent to treat drinking water that has already been tainted with PFAS. Those efforts will be for naught if we don’t stop manufacturing these harmful chemicals and allow them to recontamination water supplies. AB 246 builds off the good work the state has done in banning certain products that contain PFAS and will help ensure that limited resources for cleanup and treatment are not wasted and, more importantly, protect California’s drinking water supplies."
Arguments in Opposition
A group of stakeholders take an "opposed unless amended position" and argue, "As currently proposed, AB 246 creates significant compliance challenges for manufacturers of these covered products distributed across the North American marketplace, and it also creates new liabilities for PFAS contamination that is NOT intentionally added to a finished product. Collectively, our manufacturers do not intentionally add PFAS to serve any functional or technical effect in menstrual products… However, AB 246 intends to include PFAS not intentionally added to a menstrual product in instances where the presence of the substance is at the level of 10 parts per million (PPM), as measured in total organic fluorine. While manufacturers fully intend to comply with these prohibitions on intentionally added PFAS and understand the elevated exposure pathway menstrual products pose in use, unavoidable trace quantities of a chemical may be present. Trace quantities could be present in impurities in natural or synthetic ingredients, recycled content, manufacturing processes and equipment, and potentially through the distribution and storage of a product… The challenge of unintentional PFAS contamination is that it may extend beyond what a manufacturer can control. PFAS are ubiquitous, as they are detected in air emissions, wastewater, soils, surface water, and groundwater and can also be found with no apparent source."
FISCAL COMMENTS
This bill has little to no fiscal impact to the state and therefore met the conditions of Senate Rule 28.8.
VOTES
ASM ENVIRONMENTAL SAFETY AND TOXIC MATERIALS: 8-0-1
YES: Lee, Hoover, Arambula, Bauer-Kahan, Connolly, McKinnor, Pacheco, Zbur
ABS, ABST OR NV: Ta
ASM APPROPRIATIONS: 14-0-2
YES: Holden, Bryan, Calderon, Wendy Carrillo, Dixon, Mike Fong, Hart, Lowenthal, Papan, Pellerin, Robert Rivas, Sanchez, Weber, Wilson
ABS, ABST OR NV: Megan Dahle, Mathis
ASSEMBLY FLOOR: 70-0-10
YES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Gabriel, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones‑Sawyer, Kalra, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ting, Valencia, Villapudua, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Rendon
ABS, ABST OR NV: Megan Dahle, Essayli, Vince Fong, Friedman, Gallagher, Lackey, Jim Patterson, Joe Patterson, Ta, Waldron
SENATE FLOOR: 34-0-6
YES: Allen, Alvarado-Gil, Archuleta, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dodd, Durazo, Eggman, Glazer, Gonzalez, Hurtado, Laird, Limón, McGuire, Menjivar, Min, Newman, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
ABS, ABST OR NV: Dahle, Grove, Jones, Nguyen, Niello, Seyarto
ASSEMBLY FLOOR: 71-0-9
YES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Davies, Dixon, Mike Fong, Friedman, Gabriel, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones‑Sawyer, Kalra, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Rendon, Reyes, Luz Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ting, Valencia, Villapudua, Waldron, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Robert Rivas
ABS, ABST OR NV: Megan Dahle, Essayli, Flora, Vince Fong, Gallagher, Lackey, Jim Patterson, Joe Patterson, Ta
UPDATED
VERSION: September 12, 2023
CONSULTANT: Shannon McKinney / E.S. & T.M. / (916) 319-3965 FN: 0002522
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 246
Author:(Papan)
As Amended Ver:September 1, 2023
Majority vote
SUMMARY
Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances (PFAS).
Senate Amendments
- Delete the provisions in the bill that authorized the Attorney General (AG), a city attorney, a county counsel, or a district attorney to levy a civil penalty not to exceed $5,000 for a first violation and not to exceed $10,000 for each subsequent violation.
- Authorize, instead of the provisions above, the AG in the name of the people of the state, a district attorney, a city or county attorney, a county counsel, or a city prosecutor to bring actions pursuant to the provisions of the bill.
- Provide that a person or entity who violates the provisions of the bill is liable for a civil penalty not to exceed $10,000 per day for each violation.
- Provide that the civil penalty may be assessed and recovered in a civil action brought in any court of competent jurisdiction.
- Require, in assessing the amount of a civil penalty for a violation of the provisions of this bill, the court to consider all of the following:
- The nature and extent of the violation;
- The number of, and severity of, the violation;
- The economic effect of the penalty on the violator;
- Whether the violator took good faith measures to comply with the provisions of this bill and when these measures were taken;
- The deterrent effect that the imposition of the penalty would have on both the violator and the regulated community as a whole; and,
- Whether there were contributing environmental factors about which a reasonable person knew or should have known.
- Require that civil penalties collected pursuant to the provisions of this bill be paid to the office of the city or county attorney, city prosecutor, county counsel, district attorney, or AG, whichever office brought the action.
COMMENTS
Perfluoroalkyl and polyfluoroalkyl substances (PFAS): Per- and polyfluorinated substances (PFASs) are a large group of synthetic, highly fluorinated substances that have been widely used in industrial and consumer applications for their heat, water, and lipid resistance properties for more than seven decades. PFAS are long-lasting chemicals that break down very slowly over time. PFAS are ubiquitous, and researchers have found PFAS in indoor and outdoor environments, plants, soil, food, drinking water, wildlife, companion animals, production animals, and humans at locations across the nation and around the globe. Scientific studies have shown that exposure to some PFAS may be linked to harmful health effects in humans and animals. More than 9,000 PFAS chemicals are included in the United States Environmental Protection Agency's (US EPA's) Master List of PFAS Substances.
Exposure to PFAS: The main route of exposure to PFAS is through ingestion of contaminated food or liquid (accounting for up to half of total exposure), and through inhalation and ingestion of contaminated indoor air and dust. Food can become contaminated with PFAS through contaminated soil and water used to grow the food, food packaging containing PFAS, and equipment that uses PFAS during food processing. Some foods, such as fish, meat, eggs and leafy vegetables, may contain PFAS due to bioaccumulation and crop uptake. Studies have shown that PFAS can transfer from pregnant mothers to their fetuses via the placenta during gestation, as well as transfer from nursing mothers to their infants via breastfeeding. Dermal exposure is also possible when people touch products treated with PFAS, such as carpets or clothing. Young children may be susceptible to higher levels of exposure than adults because they ingest more dust containing PFAS and mouth PFAS-treated consumer products. Workers, such as carpet installers, carpet cleaners, firefighters, and workers in furniture, furnishings, outdoor clothing, and carpet stores, may also experience above average PFAS exposure levels.
Exposure to PFAS in drinking water is an escalating concern due to the persistence of PFAS chemicals in the environment and their tendency to accumulate in groundwater.
Hazard traits of PFAS: An intrinsic property of PFAS is the extreme environmental persistence of either the individual compounds or their degradation products or both, resulting in their classification as "forever chemicals." Most PFAS are mobile in environmental media such as air and water, and thus are widespread in living organisms and the environment. Several PFAS bioaccumulate significantly in animals or plants and emerging evidence points to their phytotoxicity, aquatic toxicity, and terrestrial ecotoxicity.
According to the US EPA, current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to: reproductive effects such as decreased fertility or increased high blood pressure in pregnant women; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body's immune system to fight infections, including reduced vaccine response; interference with the body’s natural hormones; and, increased cholesterol levels and/or risk of obesity.
Regulating PFAS as a class: The Department of Toxic Substances Control has adopted a rationale for regulating PFAS chemicals as a class, concluding, "it is both ineffective and impractical to regulate this complex class of chemicals with a piecemeal approach." This rationale was presented in the February, 2021, Environmental Health Perspectives article, "Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program," which states, "The widespread use, large number, and diverse chemical structures of PFAS pose challenges to any sufficiently protective regulation, emissions reduction, and remediation at contaminated sites. Regulating only a subset of PFAS has led to their replacement with other members of the class with similar hazards, that is, regrettable substitutions… Regulating PFAS as a class is thus logical, necessary, and forward-thinking."
PFAS in menstrual products: In the United States, approximately 72.7 million women are of reproductive age (15 - 49). During the reproductive stage of their lives, people who menstruate rely on a diverse range of menstrual products, from tampons to pads to menstrual cups to period underwear. To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. Conducted at US EPA-certified laboratories between 2020 and 2022, the tests detected organic fluorine, a marker for PFAS, in several menstrual products. For example, 22% of the 23 tampon products tested had indications of PFAS, including 2 products advertised as "organic." Forty eight percent of 46 different sanitary pads, panty liners, and incontinence pads tested had indications of PFAS, including several products marketed as "organic" and "natural." Sixty-five percent of period underwear products tested, and 57% of the period underwear brands tested, had detectable levels of fluorine present. Exposure to PFAS through menstrual products is particularly concerning because the vagina is an extremely vascular area and dermal exposure in the vaginal area is often higher than other places of the body. Additionally, people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.
This bill: This bill prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS.
Enforcement: Like this bill, most of the state's chemical prohibition bills were placed in what is sometimes referred to as the "orphan codes." In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no compliance program, no guidance for manufacturers seeking to comply with these laws, no related information for consumers, and no state entity investigating complaints, testing products for compliance, or bringing enforcement actions against violators.
This bill: This bill provides the AG and other government attorneys with the authority to levy a civil penalty, as specified, not to exceed $10,000 per day for each violation of the provisions of the bill. These penalty provisions are in addition to the AG's existing authority to enforce this, and related product safety statutory provisions, such as through the Unfair Competition Law.
According to the Author
"These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAS in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
AB 246 takes a critical step towards protecting women's health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California's pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women's health must be prioritized over the use of these unnecessary chemicals. It's past time to protect women and our environment."
Arguments in Support
California Water Service (Cal Water) argues in support of the bill, "Each year, we invest hundreds of millions of dollars into our water systems to ensure we continue to deliver a reliable supply of high-quality drinking water. We continue monitoring our water sources for PFAS and are taking action where needed. From removing water supply sources from service to constructing new water treatment facilities, Cal Water has worked diligently to ensure the safety of the drinking water we provide to our customers… In the coming years, substantial amounts of money will be spent to treat drinking water that has already been tainted with PFAS. Those efforts will be for naught if we don’t stop manufacturing these harmful chemicals and allow them to recontamination water supplies. AB 246 builds off the good work the state has done in banning certain products that contain PFAS and will help ensure that limited resources for cleanup and treatment are not wasted and, more importantly, protect California’s drinking water supplies."
Arguments in Opposition
A group of stakeholders take an "opposed unless amended position" and argue, "As currently proposed, AB 246 creates significant compliance challenges for manufacturers of these covered products distributed across the North American marketplace, and it also creates new liabilities for PFAS contamination that is NOT intentionally added to a finished product. Collectively, our manufacturers do not intentionally add PFAS to serve any functional or technical effect in menstrual products… However, AB 246 intends to include PFAS not intentionally added to a menstrual product in instances where the presence of the substance is at the level of 10 parts per million (PPM), as measured in total organic fluorine. While manufacturers fully intend to comply with these prohibitions on intentionally added PFAS and understand the elevated exposure pathway menstrual products pose in use, unavoidable trace quantities of a chemical may be present. Trace quantities could be present in impurities in natural or synthetic ingredients, recycled content, manufacturing processes and equipment, and potentially through the distribution and storage of a product… The challenge of unintentional PFAS contamination is that it may extend beyond what a manufacturer can control. PFAS are ubiquitous, as they are detected in air emissions, wastewater, soils, surface water, and groundwater and can also be found with no apparent source."
FISCAL COMMENTS
This bill has little to no fiscal impact to the state and therefore met the conditions of Senate Rule 28.8.
VOTES:
ASM ENVIRONMENTAL SAFETY AND TOXIC MATERIALS: 8-0-1
YES: Lee, Hoover, Arambula, Bauer-Kahan, Connolly, McKinnor, Pacheco, Zbur
ABS, ABST OR NV: Ta
ASM APPROPRIATIONS: 14-0-2
YES: Holden, Bryan, Calderon, Wendy Carrillo, Dixon, Mike Fong, Hart, Lowenthal, Papan, Pellerin, Robert Rivas, Sanchez, Weber, Wilson
ABS, ABST OR NV: Megan Dahle, Mathis
ASSEMBLY FLOOR: 70-0-10
YES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Gabriel, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Pellerin, Petrie‑Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ting, Valencia, Villapudua, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Rendon
ABS, ABST OR NV: Megan Dahle, Essayli, Vince Fong, Friedman, Gallagher, Lackey, Jim Patterson, Joe Patterson, Ta, Waldron
SENATE FLOOR: 34-0-6
YES: Allen, Alvarado-Gil, Archuleta, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dodd, Durazo, Eggman, Glazer, Gonzalez, Hurtado, Laird, Limón, McGuire, Menjivar, Min, Newman, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
ABS, ABST OR NV: Dahle, Grove, Jones, Nguyen, Niello, Seyarto
UPDATED
VERSION: September 1, 2023
CONSULTANT: Shannon McKinney / E.S. & T.M. / (916) 319-3965 FN: 0001927
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 246 |
THIRD READING
Bill No: AB 246
Author: Papan (D), et al.
Amended: 9/1/23 in Senate
Vote: 21
SENATE ENVIRONMENTAL QUALITY COMMITTEE: 5-0, 6/21/23
AYES: Allen, Gonzalez, Hurtado, Menjivar, Skinner
NO VOTE RECORDED: Dahle, Nguyen
SENATE JUDICIARY COMMITTEE: 10-0, 7/6/23
AYES: Umberg, Wilk, Allen, Ashby, Caballero, Durazo, Laird, Min, Stern, Wiener
NO VOTE RECORDED: Niello
SENATE APPROPRIATIONS COMMITTEE: Senate Rule 28.8
ASSEMBLY FLOOR: 70-0, 5/15/23 - See last page for vote
SUBJECT: Product safety: menstrual products: perfluoroalkyl and polyfluoroalkyl substances
SOURCE: Author
DIGEST:
Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS) or, commencing January 1, 2027, concentrations of PFAS at or above 10 parts per million (ppm).
Senate Floor Amendments of 9/1/23 make changes to the enforcement provisions by specifying considerations a court shall make in determining the amount of a civil penalty for a violation of the prohibitions in this bill, specifying further who may bring actions pursuant to this section, and specifying where civil penalties shall be paid to.
ANALYSIS: Existing law, under the Menstrual Products Right to Know Act of 2020, requires a package containing menstrual products manufactured on or after January 1, 2023 for sale or distribution in the state to be labeled with all ingredients in the product by weight and this information to be posted on the internet.
This bill:
- Defines “menstrual product” as a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
- Defines “perfluoroalkyl and polyfluoroalkyl substances” or “PFAS” as a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
- Prohibits a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain:
- Commencing January 1, 2025, PFAS that a manufacturer has intentionally added to a product and that has a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
- Commencing January 1, 2027, PFAS in a product or product component at or above 10 parts per million (ppm), as measured in total organic fluorine.
- Requires a manufacturer to use the least toxic alternative, including alternative design, when removing regulated PFAS in menstrual products to comply with the restrictions in this bill.
- Requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance with the requirements of this bill.
- Provides that a distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of the provisions in this bill if they relied in good faith on the certificate of compliance.
- Provides that a person or entity that violates the prohibitions in this bill shall be liable for a civil penalty not to exceed $10,000 per day for each violation.
- Provides that the civil penalties may be assessed and recovered in any a court of competent jurisdiction.
- Provides that an action to enforce the prohibitions in this bill may be brought by Attorney General in the name of the people of the state, by a district attorney, by a city or county attorney, by a county counsel, or by a city prosecutor.
- Provides that that civil penalties shall be paid to the office that brought the action.
- Requires the court in assessing the amount of the civil penalty to consider:
- The nature and extent of the violation;
- the number of, and severity of, the violations;
- The economic effect of the penalty on the violator;
- Whether the violator took good faith measures to comply with this chapter and when these measures were taken;
- The deterrent effect that the imposition of the penalty would have on the violator and the regulated community; and
- Whether there were contributing environmental factors about which a reasonable person knew or should have known.
- Provides that these penalty provisions do not impair or impede any other rights, causes of action, claims, or defenses available under any other law. Provides that the remedies delineated in the bill are cumulative with any other remedies available under any other law.
Background
- Perfluoroalkyl and polyfluoroalkyl substances (PFAS). Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic substances that have been widely used in industrial and consumer applications for their heat, water, and oil resistance properties since their invention in the 1930s. PFAS are used extensively in carpets, furniture fabrics, apparel, paper packaging for food, non-stick cookware, personal care products, and other products designed to be waterproof; grease, heat, water and stain resistant; or, non-stick. Commercial applications span many sectors of the economy, including aerospace, apparel, automotive, building and construction, pharmaceuticals, medical devices, paints, electronics, semiconductors, energy, oil and gas exploration, first responder safety, firefighting foams, and health care.
Scientific studies have shown that exposure to some PFAS may be linked to harmful health effects in humans and animals. PFAS are long-lasting chemicals that break down very slowly over time. During production, use, and disposal, PFAS can migrate into the soil, water, and air. PFAS have been found in indoor and outdoor environments, plants, soil, food, drinking water, wildlife and domestic animals, and humans. The persistence and proliferation of PFAS chemicals makes it challenging to study and assess the overall potential human health and environmental risks of PFAS exposure.
- Hazards of PFAS. PFAS exposure occurs mainly through ingestion of contaminated food or liquids. Exposure can also occur though inhalation and touch, and PFAS can be transferred through pregnancy and breastfeeding. PFAS remains in the body for a long time, so as people continue to be exposed to PFAS, the PFAS levels in their bodies may increase to the point that they suffer adverse health effects. According to the United States Environmental Protection Agency (US EPA), current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to reproductive effects such as decreased fertility or increased high blood pressure in pregnant people; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body’s immune system to fight infections, including reduced vaccine response; interference with the body’s natural hormones; and, increased cholesterol levels and/or risk of obesity.
Comments
- Purpose of Bill. According to the author, “These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAs in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
“AB 246 takes a critical step towards protecting women’s health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California’s pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women’s health must be prioritized over the use of these unnecessary chemicals. It’s past time to protect women and our environment.”
- PFAS in menstrual products. People who menstruate rely on a diverse range of menstrual products, such as tampons, pads, menstrual cups, or period underwear. In the United States, this is approximately 72.7 million people between the ages of 15-49. Exposure to PFAS through menstrual products is particularly concerning because the vagina is an area with high blood flow where toxins can be taken up through the skin more readily than other places on the body. Additionally, people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.
To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. The tests for this study were conducted at US EPA-certified laboratories between 2020 and 2022 and detected organic fluorine, a marker for PFAS, in several menstrual products. The study found PFAS at concentrations ranging from 19 to 28 ppm in 22% of 23 tested tampon products. Of 46 sanitary pads, panty liners, and incontinence pads tested, 48% showed concentrations ranging from 11 to 154 ppm. Additional tests of period underwear products found that 65% had PFAS at concentrations ranging from 10 to 940 ppm. Detections of PFAS at concentrations greater than 3,000 ppm in period underwear had previously led to a high-profile lawsuit against the manufacturer, which was settled in January 2023.
- Who is in charge? Many chemical prohibition bills, including this one, are placed in a unique location in the California Codes, sometimes referred to as the “orphan codes.” In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no direct enforcement, no establishment of standardized testing methods, no compliance program, no guidance for manufacturers seeking to comply with these laws, and no related information for consumers. Because of these deficiencies, it is challenging for some manufacturers to comply and difficult or impossible to know if manufacturers are complying with the requirements of the law.
The only current option for enforcement of the prohibitions in the “orphan codes” is for a district attorney or the state Attorney General to bring an action against a manufacturer under the Unfair Competition Law (UCL), unless specified otherwise. This bill takes a step forward on statutory chemical prohibitions by adding civil penalties for violations of the restrictions in the bill. These penalty provisions are in addition to the authority to enforce under the UCL.
- PFAS concentration thresholds. This and several other PFAS prohibitions prohibit intentionally added PFAS and additionally set a concentration threshold for any PFAS in a product, intentionally added or not. Such a threshold may be warranted because determining whether PFAS were intentionally added in the manufacturing of a product can be a challenge when certain manufacturing information is proprietary or contaminated product components are used. Setting a concentration threshold can further protect public health, but the chosen concentration should be appropriate. As with enforcement, determining an acceptable level of exposure could benefit from a public entity with scientists with health and environmental backgrounds determining the risks of chemical exposure at different levels. Without that resource, the Legislature is tasked with setting a protective standard in statute. There is no concentration of PFAS that has been proven safe, and as long-lasting chemicals, they build up in the human body and in the environment over time. PFAS in different types of products may be of greater concern than others depending on how likely the chemicals are to enter the body. A menstrual product containing PFAS likely poses a more acute health risk than, for example, a jacket containing PFAS. In 2027, the same time the 10 ppm threshold of this bill would go into effect, certain textiles, including clothing, may not contain more than 50 ppm of PFAS under AB 1817 (Ting, 2022). Any PFAS in a product can eventually end up in the environment, including in drinking water.
This bill prohibits intentionally added PFAS in menstrual products and commencing January 1, 2027, PFAS at or above 10 ppm, as measured in total organic fluorine. Concerns have been raised by the opposition that the 10 ppm threshold is too low. These assert that unavoidable trace quantities of PFAS through the manufacturing processes could exceed this value and that detection methods for concentrations as low as 10 ppm can be unreliable. Laboratories appear to conduct testing on a variety of products for total organic fluorine at concentrations below 10 ppm. Testing sensitivities have improved over time and the author indicates that an implementation date of 2027 leaves time for more accurate and reliable tests to become more widespread.
Related/Prior Legislation
AB 1817 (Ting, Chapter 762, Statutes of 2022) prohibits, beginning January 1, 2024, a person from distributing, selling, or offering for sale in the state a textile article, as defined, that contains intentionally added PFAS, or starting January 1, 2025, any PFAS at concentrations of 100 ppm or more, or starting January 1, 2027, 50 ppm or more.
[NOTE: See the Senate Environmental Quality Committee analysis for detailed background of this bill.]
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
SUPPORT: (Verified 9/1/23)
A Voice for Choice Advocacy
American College of Obstetricians and Gynecologists District Ix
Breast Cancer Prevention Partners
California Association of Sanitation Agencies
California Legislative Women's Caucus
California Professional Firefighters
California Water Service
Californians Against Waste
CALPIRG
Center for Public Environmental Oversight
City of Camarillo
Clean Seas Lobbying Coalition
Clean Water Action
Cleanearth4kids.org
Environmental Working Group
Green Science Policy Institute
Irvine Ranch Water District
Los Angeles County Sanitation Districts
Naral Pro-choice California
National Stewardship Action Council
Natural Resources Defense Council (NRDC)
Republic Services - Western Region
Responsible Purchasing Network
San Diego County Water Authority
Sierra Club California
Solano County Democratic Central Committee
Weideman Group
Women's Voices for The Earth
OPPOSITION: (Verified 9/1/2023)
California Manufacturers and Technology Association
ARGUMENTS IN SUPPORT: According to supporters, “With the threshold, AB 246 is in line with other bills passed by this Legislature to ban PFAS in textiles, children’s products, and food packaging by defining regulated PFAS as PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, as well as the presence of PFAS in a product or product component at or above a specified threshold, as measured in total organic fluorine. Setting a robust threshold is especially important in AB 246 because it addresses the use of PFAS in products that are used within, or in close contact with sensitive parts of women’s bodies. Given that these chemicals are associated with reproductive harm, cancers, immune system interference and other serious health impacts, they have no business being used in such intimate personal care products. In addition, their use can contribute to water contamination when reusable products are laundered or others are disposed of.”
ARGUMENTS IN OPPOSITION: According to the California Manufacturers & Technology Association (CMTA): “The challenge presented with unintentional PFAS contamination is that it may extend beyond what a manufacturer can control. PFAS are ubiquitous, as they are detected in air emissions, wastewater, soils, surface water, and groundwater and can also be found with no obvious source at all. Expanding state legislative policy that now includes unintentionally added PFAS requires further regulatory guidance and oversight from state regulators. We know that product testing data down to ten parts per million (PPM) is often unreliable, especially given that PFAS are not intentionally added to serve any functional or technical effect in a product.”
ASSEMBLY FLOOR: 70-0, 5/15/23
AYES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Gabriel, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ting, Valencia, Villapudua, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Rendon
NO VOTE RECORDED: Megan Dahle, Essayli, Vince Fong, Friedman, Gallagher, Lackey, Jim Patterson, Joe Patterson, Ta, Waldron
Prepared by: Theresa Keates / E.Q. / (916) 651-4108
9/4/23 10:18:16
**** END ****
Senator Thomas Umberg, Chair
2023-2024 Regular Session
Bill No: AB 246 (Author:Papan)
Version: April 12, 2023
Hearing Date: July 6, 2023
Fiscal: Yes
Urgency: No
Consultant: AM
SUBJECT
Product safety: menstrual products: perfluoroalkyl and polyfluoroalkyl substances
DIGEST
This bill prohibits, beginning January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS). The bill also prohibits, beginning January 1, 2027, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain, whether intentionally or unintentionally, concentrations of PFAS at or above 10 parts per million (ppm). The bill makes a violation of these provisions punishable by a civil penalty not to exceed $5,000 for a first violation, and $10,000 for each subsequent violation.
EXECUTIVE SUMMARY
PFAS are a large group of synthetic substances that have been widely used in industrial and consumer applications for their heat, water, and oil resistance properties since their invention in the 1930s. They are often referred to as “forever chemicals” due to the long time they take to break down. These chemicals are pervasive and have been found almost everywhere—indoor and outdoor environments, plants, food, soil, drinking water, wildlife, domestic animals, and humans. Studies have shown that exposure to PFAS may be linked to hazardous health effects and that PFAS can be transferred through ingestion or touch. California has enacted several laws banning PFAS in various products, such as textiles and children’s products. This bill seeks to ban PFAS in menstrual products given the elevated exposure pathway of the products.
The bill is author sponsored and supported by numerous organizations, including local governments, organizations that advocate for reproductive health and environmental organizations. The bill has been designated as a top priority for the California Legislative Women’s Caucus. The bill is opposed unless amended by the several associations representing manufacturers of menstrual products. The bill passed the Senate Environmental Quality Committee on a vote of 5 to 0.
PROPOSED CHANGES TO THE LAW
Existing law:
- Requires, pursuant to the Menstrual Products Right to Know Act of 2020, that a package containing menstrual products manufactured on or after January 1, 2023 for sale or distribution in the state to be labeled with all ingredients in the product by weight and this information to be posted on the internet. (Health & Saf. Code § 111822 et. seq.)
- Prohibits, beginning January 1, 2022, a manufacturer of class B firefighting foam from manufacturing, or knowingly selling, offering for sale, distributing for sale, or distributing for use, and a person from using, class B firefighting foam containing intentionally added PFAS chemicals. (Health & Saf. Code § 13061(b)(1).)
- Prohibits, beginning on January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously used, textile articles that contain intentionally added PFAS, or PFAS at or above 100 PPM, and on or after January 1, 2027, 50 PPM, as measured in total organic fluorine. (Health & Saf. Code § 108971.)
- Prohibits, commencing on January 1, 2023, a person from distributing, selling, or offering for sale in the state any food packaging that contains intentionally added PFAS or PFAS at or above 100 ppm, as measured in total organic fluorine. (Health & Saf. Code §109000.)
- Authorizes the State Water Resources Control Board (State Water Board) to order a public water system to monitor for PFAS; requires community water systems to report detections; and, where a detected level of these substances exceeds the response level, to take a water source out of use or provide a prescribed public notification. (Health & Saf. Code § 116378.)
- Requires the Department of Toxic Substances Control (DTSC) to adopt regulations to establish a process to identify and prioritize chemicals or chemical ingredients in consumer products that may be considered chemicals of concern, as specified. (Health & Saf. Code §25252.)
- Requires DTSC to adopt regulations to establish a process to evaluate chemicals of concern in consumer products, and their potential alternatives, to determine how to best limit exposure or to reduce the level of hazard posed by a chemical of concern. (Health & Saf. Code §25253(a).)
- Specifies, but does not limit, regulatory responses that DTSC can take following the completion of an alternatives analysis, ranging from no action, to a prohibition of the chemical in the product. (Health & Saf. Code § 25253.)
This bill:
- Prohibits, beginning January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS), as defined. The bill makes a violation of these provisions punishable by a civil penalty not to exceed five thousand dollars ($5,000) for a first violation, and not to exceed ten thousand dollars ($10,000) for each subsequent violation, and authorizes the Attorney General, a city attorney, a county counsel, or a district attorney to bring an action to enforce these provisions.
- Prohibits, beginning January 1, 2027, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain, whether intentionally or unintentionally, concentrations of PFAS at or above 10 parts per million (ppm).
- Provides that a person or entity that violates of these provisions is liable for a civil penalty not to exceed $5,000 for a first violation, and not to exceed $10,000 for each subsequent violation, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney.
- Specifies that these provisions do not impair or impede any other rights, causes of action, claims, or defenses available under any other law. The remedies provided in this bill are cumulative with any other remedies available under any other law.
- Requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of these provisions and does not contain any regulated PFAS.
- Specifies that a distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, will not be held in violation of these provisions if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to 5), above.
- Defines various terms for these purposes.
- “Manufacturer” means either of the following:
- a person or entity who manufactures the designated product and whose name appears on the product label; or
- a person or entity who the product is manufactured for or distributed by, as identified on the product label pursuant to the federal Fair Packaging and Labeling Act.
- “Menstrual product” means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
- “Perfluoroalkyl and polyfluoroalkyl substances” or “PFAS” means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
- “Regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS” means either of the following:
- PFAS that a manufacturer has intentionally added to a product and that has a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product; or
- commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million, as measured in total organic fluorine.
- “Manufacturer” means either of the following:
COMMENTS
- Stated need for the bill
The author writes:
These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAS in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
AB 246 takes a critical step towards protecting women’s health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California’s pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women’s health must be prioritized over the use of these unnecessary chemicals. It’s past time to protect women and our environment.
- Bill bans PFAS in menstrual products
This bill was first heard by the Senate Environmental Quality Committee, which has primary jurisdiction over the majority of the provisions in this bill, including, but not limited to, the effects of PFAS on the environment and human health, the level of PFAS that is acceptable in menstrual products, how PFAS should be measured under the bill’s provisions, and the existing and future testing capabilities for PFAS. As such this analysis will focus on the provisions of this bill in the primary jurisdiction of this Committee, mainly the enforcement mechanism of the bill through the imposition of civil penalties. For a detailed analysis of PFAS and the environmental effects see the Senate Environmental Quality Committee analysis of this bill.[1]
This bill intends to address the issue of PFAS in menstrual products in two ways. First, it prohibits a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain intentionally added PFAS beginning January 1, 2025. Second, the bill prohibits, beginning January 1, 2027, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain concentrations of PFAS at or above 10 parts per million (ppm), regardless if intentionally or unintentionally added.
- PFAS in menstrual products
The Senate Environmental Quality Committee notes that in the U.S. “approximately 72.7 million women are of reproductive age (15-49).[2]” That Committee noted “[e]xposure to PFAS through menstrual products is particularly concerning because the vagina is an extremely vascular area and dermal exposure in the vaginal area is often higher than other places of the body” and “people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.”[3] That Committee further noted:
According to the US EPA, current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to: reproductive effects such as decreased fertility or increased high blood pressure in pregnant women; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body’s immune system to fight infections, including reduced vaccine response; interference with the body’s natural hormones; and, increased cholesterol levels and/or risk of obesity.[4]
In regards the evidence provided about the existence of PFAS in menstrual products, that Committee stated:
To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. The tests for this study were conducted at US EPA-certified laboratories between 2020 and 2022 and detected organic fluorine, a marker for PFAS, in several menstrual products. The study found PFAS at concentrations ranging from 19 to 28 ppm in 22% of 23 tested tampon products. Of 46 sanitary pads, panty liners, and incontinence pads tested, 48% showed concentrations ranging from 11 to 154 ppm. Additional tests of period underwear products found that 65% had PFAS at concentrations ranging from 10 to 940 ppm. Detections of PFAS at concentrations greater than 3,000 ppm in period underwear had previously led to a high-profile lawsuit against the manufacturer, which was settled in January 2023.[5]
- California has a long history of regulating PFAS in consumer products and is not alone in regulating these “forever chemicals”
The Legislature has enacted numerous bills addressing the issue of PFAS at different levels across various products—see the Prior Legislation section, below. California is not the only state concerned with PFAS, as just this year 195 new bills were introduced in dozens of state legislatures across the country seeking to ban PFAS in an expanding list of products.[6] Earlier this year, the European Union (EU), proposed an across-the-board ban on the use of PFAS that, if adopted, would likely become effective in 2027—the same year that the ban on the unintentional level of PFAS at 10 ppm would go into effect under this bill. However, the proposal is in initial stages and currently undergoing a consultation period where stakeholders may provide comments to the European Chemical Agency before final adoption, and as such could change from its current form. The current proposal suggests two potential regulatory approaches: one approach would include a total ban on PFAS above a threshold amount after a limited 18-month transition period, and the second approach would include a similar ban except there would be limited exemptions and/or phase-ins for certain as yet defined categories of PFAS use, which would likely be time-limited as well. The EU’s proposal would ban concentration limits in mixtures and articles above 25 parts per billion of any PFAS (based on targeted analysis), 250 parts per billion of any combination of PFAS substances (either based on targeted analysis of a sample, or after chemical degradation of a sample), and 50 parts per million of PFAS (inclusive of polymeric PFAS).[7] The third standard applies where the first two standards are not applicable (e.g., for fluoropolymers).[8]
- Opposition concerns
The bill’s opposition is opposed unless amended to address their concerns with the bill. The opposition has no issue with the ban on intentionally added PFAS and have stated that none of their members intentionally add PFAS to the menstrual products they manufacture. They claim that PFAS chemicals are ubiquitous in the environment and can be present in natural or synthetic ingredients, recycled content, manufacturing processes and equipment, and potentially through the storage of the product and, therefore, unintentional PFAS contamination may extend beyond what a manufacturer can control.
According to the opposition, testing products down to 10 ppm is often unreliable. They further note that Vermont is currently considering legislation to ban PFAS in specified products, including menstrual products, but the Vermont legislation provides a manufacturer would not be considered in violation of the prohibition if the product contains technically unavoidable trace quantities of PFAS when the trace quantity is the result of: natural or synthetic ingredients, the manufacturing process, storage; or migration from packaging.[9] They would like similar language in this bill. They also would like clarity around what each violation in the bill constitutes, and the ability to be given a notice of any potential violation and 180 days to come into compliance with the bill’s provisions.
The Senate Environmental Quality Committee analyzed the unintentional PFAS threshold and concluded:
Such a threshold may be warranted because determining whether PFAS were intentionally added in the manufacturing of a product can be a challenge when certain manufacturing information is proprietary or contaminated product components are used. Setting a concentration threshold can further protect public health, but the chosen concentration should be appropriate. There is no concentration of PFAS that has been proven safe, and as long-lasting chemicals, they build up in the human body and in the environment over time. PFAS in different types of products may be of greater concern than others depending on how likely the chemicals are to enter the body. A menstrual product containing PFAS likely poses a more acute health risk than, for example, a jacket containing PFAS. Even if direct exposure to the product is limited, any PFAS in a product can, eventually, end up in the environment, including in drinking water.[10]
Supporters of the bill also note that several other bills have enacted a ban on unintentional PFAS, including AB 1817 (Ting, Chapter 762, Statutes of 2022) for textiles at 100 ppm as of 2025 and 50 ppm as of 2027, AB 1200 (Ting, Chapter 503, Statutes of 2021) food packaging at 100 ppm, and AB 652 (Freidman, Chapter 500, Statutes of 2021) children’s products at 100 ppm. These bills all made the unintentional ban effective immediately or, in the case of AB 1817, provided for a step down approach.
- Enforcement mechanism under the bill
This bill provides for enforcement through civil liability. A violation of these provisions, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, makes a person liable for a civil penalty not to exceed $5,000 for a first violation, and not to exceed $10,000 for each subsequent violation. The bill expressly states that it does not impair or impede any other rights, causes of action, claims, or defenses available under any other law, and that the remedies provided in this section are cumulative with any other remedies available under any other law. The enforcement mechanism in the bill is unclear as to what “each violation” means. Does it mean each individual menstrual product, each box, or other measurement?
The author states that the enforcement provision in this bill is modeled after the one provided for in SB 1044 (Allen, Ch. 308, Stats. 2020), which prohibited the manufacture, sale, distribution, and use of firefighting foam containing PFAS chemicals by January 1, 2022. SB 1044 was not heard by this Committee. SB 1044 applied to the intentional addition of PFAS in firefighter personal protective equipment and firefighting foam. Additionally, the products SB 1044 applied to are very different in how they are manufactured and sold than menstrual products. The other PFAS prohibition bills mentioned earlier in the analysis also did not go through this Committee as they did not contain specific civil penalty enforcement language. Those bills prohibitions would therefore need to be enforced through other existing statutory frameworks, such as the Unfair Competition Law (UCL). (Bus. & Prof. Code § 17200 et seq.) The UCL provides remedies for “anything that can properly be called a business practice and that at the same time is forbidden by law.” (Cel-Tech Communications, Inc. v. Los Angeles Cellular Telephone Co. (1999) 20 Cal.4th 163, 180 [citations omitted].)
Due process concerns may call for more specificity into what each violation means in order to provide adequate notice to manufacturers on how to comply with the bill’s provisions. As such, the Committee may wish to amend the bill to specify that a violation is each noncompliant product, and that products belonging to the same stock keeping unit (SKU) as the noncompliant menstrual product is considered part of the same, single violation. In order to ensure that the civil penalty effectively serves as a deterrence, the Committee may also wish to amend the bill to make the civil penalty be $10,000 per day for each violation.
Lastly, the bill requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of these provisions and does not contain any regulated PFAS. A similar provision is included in the textile PFAS prohibition statute (AB 1817 (Ting, Chapter 762, Statutes of 2022.) A distributor or retailer, so long as they are not also the manufacturer, will not be held in violation of these provisions if they relied in good faith on the certificate of compliance provided by the manufacturer.
- Proposed amendments
The specific amendments to address the issues regarding the enforcement mechanism raised above are:[11]
Section 108986 as added to the Health and Safety Code is amended to read:
(a) Commencing January 1, 2025, no person shall manufacture, distribute, sell, or offer for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS.
(b) A manufacturer shall use the least toxic alternative, including alternative design, when removing regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS in menstrual products to comply with this chapter.
(c) A manufacturer of a menstrual product shall provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this chapter and does not contain any regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS. A certificate of compliance provided pursuant to this subdivision shall be signed by an authorized official of the manufacturer. The certificate of compliance may be provided electronically.
(d) A distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of this chapter if they relied in good faith on the certificate of compliance provided by the manufacturer pursuant to subdivision (c).
(e) (1) Upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a A person or entity that violates this section shall be liable for a civil penalty not to exceed five thousand dollars ($5,000) for a first violation, and not to exceed ten thousand dollars ($10,000) per day for each subsequent violation. violation. The civil penalties under this subdivision shall begin accruing on the date an action is brought pursuant to paragraph (2).
(2) An action to enforce this section may be brought by the Attorney General, a city attorney, a county counsel, or a district attorney in a court of competent jurisdiction.
(3) For purposes of this section, a violation is deemed to have occurred upon the manufacture, distribution, sale, or offer for sale, as applicable, of a menstrual product in violation of this section. Menstrual products that belong to the same stock keeping unit (SKU) as the menstrual product in violation of this section and that are manufactured, distributed, sold, or offered for sale, as applicable, prior to an action brought under paragraph (2) are considered part of the same, single violation.
(2) (f) This section does not impair or impede any other rights, causes of action, claims, or defenses available under any other law. The remedies provided in this section are cumulative with any other remedies available under any other law.
- Statements in support
A coalition of environmental organizations and health advocacy groups write in support stating:
AB 246 is in line with other bills passed by this Legislature to ban PFAS in textiles, children’s products, and food packaging by defining regulated PFAS as PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product as well as the presence of PFAS in a product or product component at or above a specified threshold, as measured in total organic fluorine.
Setting a robust threshold is especially important in AB 246 because it addresses the use of PFAS in products that are used within, or in close contact with sensitive parts of women’s bodies. Given that these chemicals are associated with reproductive harm, cancers, immune system interference and other serious health impacts, they have no business being used in such intimate personal care products. In addition, their use can contribute to water contamination when reusable products are washed or others are disposed of.
Given our experience working on PFAS related bans over the years, we would respectfully point out that AB 246 does break with precedent by delaying the threshold for unintentional PFAS for two years. The aforementioned bills all established thresholds upon the bill’s effective date. In the case of textiles, it was clear that testing capacities change with time. As a result, AB 1817 (Ting-2022) had an interim threshold upon the bill’s effective date while lowering it significantly 2 years later. Given the exposure potential associated with menstrual products, while we support the bill, we would strongly recommend that AB 246 align with this precedent and set either the 10 ppm threshold in 2025 or set a less stringent threshold initially and lower it to 10 in 2027 to give companies time to do the necessary testing.
- Statements in opposition
A coalition of associations representing manufacturers of menstrual products write in opposition unless amended stating:
As currently proposed, AB 246 creates significant compliance challenges for manufacturers of these covered products distributed across the North American marketplace, and it also creates new liabilities for PFAS contamination that are NOT intentionally added to a finished product. Collectively, our manufacturers do not intentionally add PFAS to serve any functional or technical effect in menstrual products. […]
However, AB 246 intends to include PFAS not intentionally added to a menstrual product in instances where the presence of the substance is at the level of 10 parts per million (PPM), as measured in total organic fluorine. This threshold is a significant departure from previous legislative policies like SB 1044 (Allen, 2020), AB 1200 (Ting, 2021), AB 652 (Friedman, 2021), AB 1817 (Ting, 2022), and AB 2771 (Friedman, 2022). […]
The challenge presented with unintentional PFAS contamination is that it may extend beyond what a manufacturer can control. PFAS are ubiquitous, as they are detected in air emissions, wastewater, soils, surface water, and groundwater and can also be found with no obvious source at all. Expanding state legislative policy that now includes unintentionally added PFAS requires further regulatory guidance and oversight from state regulators. We know that product testing data down to ten parts per million (PPM) is often unreliable, especially given that PFAS are not intentionally added to serve any functional or technical effect in a product. The state may find it much more prudent to establish a threshold of 100PPM while also authorizing California’s Department of Toxic and Substances Control (DTSC) to determine whether PFAS thresholds should be modified based on an evaluation of the accuracy and precision of available testing methodologies.
SUPPORT
A Voice for Choice Advocacy
American College of Obstetricians and Gynecologists District IX
Breast Cancer Prevention Partners
California Association of Sanitation Agencies
California Professional Firefighters
California Water Service
Californians Against Waste
CALPIRG
Center for Public Environmental Oversight
City of Camarillo
CleanEarth4Kids.org
Clean Seas Lobbying Coalition
Clean Water Action
Environmental Working Group
Green Science Policy Institute
Irvine Ranch Water District
Legislative Women’s Caucus
Los Angeles County Sanitation Districts
NARAL Pro-Choice California
National Stewardship Action Council
Natural Resources Defense Council
Orange County Sanitation District
Republic Services
Responsible Purchasing Network
San Diego County Water Authority
Sierra Club California
Solano County Democratic Central Committee
Women's Voices for the Earth
Yorba Linda Water District
OPPOSITION
American Chemistry Council
American Forest & Paper Association
California Manufacturers & Technology Association
Center for Baby and Adult Hygiene Products
Consumer Healthcare Products Association
RELATED LEGISLATION
Pending Legislation:
AB 727 (Weber, 2023) prohibits, beginning January 1, 2025, a person from manufacturing, selling, delivering, distributing, holding, or offering for sale, a cleaning product that contains intentionally-added PFAS or PFAS at or above 50 PPM, and on January 1, 2027, a cleaning product that contains PFAS at or above 25 PPM. AB 727 will be heard in this Committee on the same day as this bill.
AB 1423 (Schiavo, 2023) prohibits, commencing January 1, 2025, a person or entity from manufacturing, distributing, selling, or offering for sale in the state any covered surface that contains PFAS, as defined, and prohibits, commencing January 1, 2024, a public entity, a public or private school, or a public or private institution of higher learning, as specified, from purchasing or installing a covered surface that contains PFAS. This bill is pending before the Senate Environmental Quality Committee.
Prior Legislation:
AB 1817 (Ting, Ch. 762, Stat. 2022) prohibited, beginning January 1, 2024, a person from distributing, selling, or offering for sale in the state a textile article, as defined, that contains regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with the provisions of the bill.
AB 2771 (Friedman, Ch. 804, Stats. 2022) prohibited, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added PFAS.
AB 1200 (Ting, Ch. 503, Stats. 2021) prohibited, commencing January 1, 2023, the sale of food packaging that contains PFAS; requires, commencing January 1, 2024, cookware manufacturers to label their product if it contains an intentionally added chemical on specified lists.
AB 652 (Freidman, Ch. 500, Stats. 2021) prohibited, on or after July 1, 2023, a person from selling or distributing in commerce any new juvenile products that contain PFAS.
SB 1044 (Allen, Ch. 308, Stats. 2020) prohibited the manufacture, sale, distribution, and use of firefighting foam containing intentionally added PFAS chemicals by January 1, 2022, with some exceptions, and requires notification of the presence of PFAS in the protective equipment of firefighters.
SB 1056 (Portantino, 2020) would have required the State Water Board to establish an analytical laboratory method that can be used as a tool to assess the extent of PFAS contamination in drinking water, surface water, groundwater, and wastewater. This bill was held in the Senate Environmental Quality Committee.
AB 1989 (Cristina Garcia, Ch. 272, Stats. 2020) enacted the Menstrual Products Right to Know Act of 2020.
AB 756 (Cristina Garcia, Ch. 162, Stats. 2019) authorized the State Water Board to order one or more public water systems to monitor for PFAS and required municipalities to notify consumers for PFAS detected above notification levels.
AB 958 (Ting, 2018) would have required a manufacturer of food packaging or cookware sold in the state to visibly disclose on an exterior location of the food packaging or cookware packaging a specified statement relating to the presence of PFAS in the product. This bill was held on the Senate Floor.
SB 1313 (Corbett, 2008) would have prohibited the manufacture, sale, or distribution of any food contact substance, as defined, which contains perfluorinated compounds, as defined, in any concentration exceeding 10 parts per billion. This bill was vetoed by then Governor Arnold Schwarzenegger whose veto message said, "I have signed AB 1879 (Feuer) and SB 509 (Simitian) which mark the beginning of California's historic Green Chemistry Initiative. It is within this process that chemicals like PFCs should be addressed."
PRIOR VOTES
Senate Environmental Quality Committee (Ayes 5, Noes 0)
Assembly Floor (Ayes 70, Noes 0)
Assembly Appropriations Committee (Ayes 14, Noes 0)
Assembly Environmental Safety and Toxic Materials Committee (Ayes 8, Noes 0)
**************
Sen. Environmental Quality Committee analysis of AB 246 (2023-24 Reg. Sess.) as amended April 12, 2023. ↑
Id. at 6. ↑
Id. at 6. ↑
Id. at 5. ↑
Id.at 6. ↑
Kimberly Kindy, States take matters into their own hands to ban ‘forever chemicals’, Washington Post (Jun 5, 2023), available at https://www.washingtonpost.com/politics/2023/06/05/forever-chemicals-state-bans-pfas/. ↑
European Chemical Agency, Annex V Restriction Report, v. 2 (Mar. 22, 2023) at p. 75, available at https://echa.europa.eu/documents/10162/f605d4b5-7c17-7414-8823-b49b9fd43aea. ↑
Ibid. ↑
VT Sen. Bill 25 (2023-24 Reg. Sess.). ↑
Sen. Environmental Quality Committee analysis of AB 246 (2023-24 Reg. Sess.) as amended April 12, 2023 a p. 8. ↑
The amendments may also include technical, nonsubstantive changes recommended by the Office of Legislative Counsel. ↑
SENATE COMMITTEE ON ENVIRONMENTAL QUALITY
Senator Allen, Chair
2023 - 2024 Regular
Bill No. | AB 246 | Hearing Date: | 6/21/2023 |
Author: | Papan | ||
Version: | 4/12/2023 | ||
Urgency: | No | Fiscal: | Yes |
Consultant: | Theresa Keates | ||
SUBJECT: Product safety: menstrual products: perfluoroalkyl and polyfluoroalkyl substances
DIGEST: Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS) or, commencing January 1, 2027, concentrations of PFAS at or above 10 parts per million (ppm).
ANALYSIS:
Existing law:
- Under the California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65) (HSC § 25249.5 et seq.):
- Prohibits a person, in the course of doing business, from knowingly discharging or releasing a chemical known to the state to cause cancer or reproductive toxicity into water or onto or into land where such chemical passes or probably will pass into any source of drinking water.
- Prohibits a person, in the course of doing business, from knowingly and intentionally exposing any individual to a chemical known to the state to cause cancer or reproductive toxicity without first giving clear and reasonable warning to such individual.
- Requires the Governor to publish a list of chemicals known to cause cancer or reproductive toxicity and to annually revise the list. The Office of Environmental Health Hazard Assessment (OEHHA) has listed perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), which are members of the PFAS class, as chemicals known to the state to cause developmental toxicity and cancer.
- Under the Safer Consumer Products (Green Chemistry) statutes (HSC § 25252 et seq.):
- Requires the Department of Toxic Substances Control (DTSC) to adopt regulations to establish a process to identify and prioritize chemicals or chemical ingredients in consumer products that may be considered chemicals of concern, as specified.
- Requires DTSC to adopt regulations to establish a process to evaluate chemicals of concern in consumer products, and their potential alternatives, to determine how to best limit exposure or to reduce the level of hazard posed by a chemical of concern.
- Specifies, but does not limit, regulatory responses that DTSC can take following the completion of an alternatives analysis, ranging from no action, to a prohibition of the chemical in the product.
- Under the Menstrual Products Right to Know Act of 2020, requires a package containing menstrual products manufactured on or after January 1, 2023 for sale or distribution in the state to be labeled with all ingredients in the product by weight and this information to be posted on the internet.
This bill:
- Defines “menstrual product” as a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
- Defines “perfluoroalkyl and polyfluoroalkyl substances” or “PFAS” as a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
- Prohibits a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain:
- Commencing January 1, 2025, PFAS that a manufacturer has intentionally added to a product and that has a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
- Commencing January 1, 2027, PFAS in a product or product component at or above 10 parts per million (ppm), as measured in total organic fluorine.
- Requires a manufacturer to use the least toxic alternative, including alternative design, when removing regulated PFAS in menstrual products to comply with the restrictions in this bill.
- Requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance with the requirements of this bill.
- Provides that, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a person or entity that violates the PFAS restrictions of this bill shall be liable for a civil penalty not to exceed five thousand dollars ($5,000) for a first violation, and not to exceed ten thousand dollars ($10,000) for each subsequent violation.
- Provides that these penalty provisions do not impair or impede any other rights, causes of action, claims, or defenses available under any other law. Provides that the remedies delineated in the bill are cumulative with any other remedies available under any other law.
Background
- Perfluoroalkyl and polyfluoroalkyl substances (PFAS). Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic substances that have been widely used in industrial and consumer applications for their heat, water, and oil resistance properties since their invention in the 1930s. PFAS are used extensively in carpets, furniture fabrics, apparel, paper packaging for food, non-stick cookware, personal care products, and other products designed to be waterproof; grease, heat, water and stain resistant; or, non-stick. Commercial applications span many sectors of the economy, including aerospace, apparel, automotive, building and construction, pharmaceuticals, medical devices, paints, electronics, semiconductors, energy, oil and gas exploration, first responder safety, firefighting foams, and health care.
Scientific studies have shown that exposure to some PFAS may be linked to harmful health effects in humans and animals. PFAS are long-lasting chemicals that break down very slowly over time. During production, use, and disposal, PFAS can migrate into the soil, water, and air. PFAS have been found in indoor and outdoor environments, plants, soil, food, drinking water, wildlife and domestic animals, and humans. The persistence and proliferation of PFAS chemicals makes it challenging to study and assess the overall potential human health and environmental risks of PFAS exposure.
- Hazards of PFAS. PFAS exposure occurs mainly through ingestion of contaminated food or liquids. Exposure can also occur though inhalation and touch, and PFAS can be transferred through pregnancy and breastfeeding. PFAS remains in the body for a long time, so as people continue to be exposed to PFAS, the PFAS levels in their bodies may increase to the point that they suffer adverse health effects. According to the United States Environmental Protection Agency (US EPA), current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to reproductive effects such as decreased fertility or increased high blood pressure in pregnant people; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body’s immune system to fight infections, including reduced vaccine response; interference with the body’s natural hormones; and, increased cholesterol levels and/or risk of obesity.
- Regulating PFAS as a class. There are many thousands of chemicals in the PFAS class (the US EPA’s master list of PFAS chemicals listed over 12,000 as of the writing of this analysis) and more types of PFAS can be developed. DTSC has adopted a rationale for regulating this large and diverse number of PFAS chemicals as a class rather than with a piecemeal approach. This is because all PFAS share at least one common hazard trait and regulations that focus on subsets of these chemicals have resulted in their replacement with other PFAS with similar hazards.
- DTSC’s Safer Consumer Products Program. DTSC administers the Safer Consumer Products (SCP, previously known as Green Chemistry) Program, which aims to advance the design, development, and use of products that are chemically safer for people and the environment. DTSC's approach provides science-based criteria and procedures for identifying and evaluating alternatives with the objective of replacing chemicals of concern with safer chemicals and avoiding the use of substitute chemicals that pose equal or greater harm.
Under DTSC’s SCP Program, all PFAS chemicals are “Candidate Chemicals” because they exhibit specified hazard traits. DTSC has designated two product categories that contain PFAS as “Priority Products”: carpets and rugs and certain surface treatments. A Priority Product is a consumer product identified by DTSC that contains one or more Candidate Chemicals and that has the potential to contribute to significant or widespread adverse impacts to humans or the environment. Manufacturers of a Priority Product must submit certain documentation regarding their product to DTSC and submit an alternatives analysis or they can remove the product for sale in California or remove or replace the chemical of concern. DTSC has proposed evaluating artificial turf with PFAS in its 2021-2023 Priority Product Work Plan, and previously proposed investigating PFAS in other product categories, such as food packaging and children’s products, but during the investigative period the Legislature prohibited PFAS in those product categories and it appears DTSC has shifted its resources to investigating other product/chemical combinations.
While the intent of the SCP regulations is to establish a robust and thorough regulatory process rooted in science to consider exposure to chemicals in consumer products, it has long been recognized that DTSC does not have the resources to evaluate all, or even a significant percentage of, chemicals in every consumer product application. To that end, the SCP statute does not preclude the Legislature from taking legislative action on the use of chemicals in consumer product applications. When there is credible scientific evidence to support a change in state policy to protect public health, the Legislature can respond to that science more quickly than DTSC can. However, many PFAS prohibitions, including this bill, have not been assigned to an agency and therefore lack oversight and enforcement (see “Who is in charge?” comment).
- Prior PFAS legislation. The Legislature has enacted several PFAS prohibitions in the last several years. These include PFAS prohibitions at different levels across many product categories: a ban on PFAS in textiles (AB 1817,Ting, Chapter 762, Statutes of 2022); cosmetic products (AB 2771, Friedman, Chapter 804, Statutes of 2022); food packaging (AB 1200, Ting, Chapter 503, Statutes of 2021); new juvenile products (AB 652, Freidman, Chapter 500, Statutes of 2021); and, firefighting foam (SB 1044, Allen, Chapter 308, Statutes of 2020). The Legislature also authorized the State Water Board to order public water systems to monitor for PFAS and required municipalities to notify consumers for PFAS detected above notification levels (AB 756, C. Garcia, Chapter 162, Statutes of 2019). California is not alone in this: just this year, 195 new bills were introduced in dozens of state legislatures in the country seeking to ban PFAS in an expanding list of products. In early February 2023, the European Union, which already bans certain PFAS types, proposed an across-the-board ban on the use of PFAS. If adopted, the E.U.’s ban would come into effect in 2027.
Comments
- Purpose of Bill. According to the author, “These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAs in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
“AB 246 takes a critical step towards protecting women’s health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California’s pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women’s health must be prioritized over the use of these unnecessary chemicals. It’s past time to protect women and our environment.”
- PFAS in menstrual products. People who menstruate rely on a diverse range of menstrual products, such as tampons, pads, menstrual cups, or period underwear. In the United States, this is approximately 72.7 million people between the ages of 15-49. Exposure to PFAS through menstrual products is particularly concerning because the vagina is an area with high blood flow where toxins can be taken up through the skin more readily than other places on the body. Additionally, people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.
To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. The tests for this study were conducted at US EPA-certified laboratories between 2020 and 2022 and detected organic fluorine, a marker for PFAS, in several menstrual products. The study found PFAS at concentrations ranging from 19 to 28 ppm in 22% of 23 tested tampon products. Of 46 sanitary pads, panty liners, and incontinence pads tested, 48% showed concentrations ranging from 11 to 154 ppm. Additional tests of period underwear products found that 65% had PFAS at concentrations ranging from 10 to 940 ppm. Detections of PFAS at concentrations greater than 3,000 ppm in period underwear had previously led to a high-profile lawsuit against the manufacturer, which was settled in January 2023.
- Who is in charge? Many chemical prohibition bills, including this one, are placed in a unique location in the California Codes, sometimes referred to as the “orphan codes.” In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no direct enforcement, no establishment of standardized testing methods, no compliance program, no guidance for manufacturers seeking to comply with these laws, and no related information for consumers. Because of these deficiencies, it is challenging for some manufacturers to comply and difficult or impossible to know if manufacturers are complying with the requirements of the law.
The only current option for enforcement of the prohibitions in the “orphan codes” is for a district attorney or the state Attorney General to bring an action against a manufacturer under the Unfair Competition Law (UCL), unless specified otherwise. However, this requires a member of the public to pay for the testing of a product for the presence of a prohibited chemical, and then the Attorney General or district attorney must have the resources and ability to prioritize action on these complaints. To the knowledge of this and prior Committees that have considered this bill, this kind of enforcement has not happened, nor has any comprehensive report or investigation been done on compliance with the prohibitions in the “orphan code.”
This bill takes a step forward on statutory chemical prohibitions by adding civil penalties for violations of the restrictions in the bill. These penalty provisions are in addition to the authority to enforce under the UCL, and are consistent with existing statutory penalties relating to PFAS in firefighting foam. However, there remains no entity providing guidance, including details such as testing standards, or ensuring compliance with the prohibitions. Moving forward, the authors of chemical prohibition bills, along with stakeholders, the policy committees, and the Administration, should continue to discuss effective oversight of these new and existing chemical prohibition laws.
- Regrettable substitutions. When prohibiting a toxic or otherwise hazardous chemical, it is important to avoid a replacement of the prohibited chemical with another hazardous chemical, or a chemical even more hazardous than the one prohibited. Like several other statues dealing with chemicals in the “orphan code,” this bill requires a manufacturer to use the least toxic alternative, including alternative design, when removing regulated PFAS in menstrual products to comply with the restrictions in this bill. However, without a state entity overseeing these substitutions, it is difficult to know whether manufacturers are replacing prohibited chemicals with substances that are safer or more hazardous. DTSC does have a process for this that takes a lifecycle perspective: manufacturers conduct alternative analyses which consider not only the toxicity of a chemical, but also its persistence and environmental impact.
- PFAS concentration thresholds. This and several other PFAS prohibitions prohibit intentionally added PFAS and additionally set a concentration threshold for any PFAS in a product, intentionally added or not. Such a threshold may be warranted because determining whether PFAS were intentionally added in the manufacturing of a product can be a challenge when certain manufacturing information is proprietary or contaminated product components are used. Setting a concentration threshold can further protect public health, but the chosen concentration should be appropriate. There is no concentration of PFAS that has been proven safe, and as long-lasting chemicals, they build up in the human body and in the environment over time. PFAS in different types of products may be of greater concern than others depending on how likely the chemicals are to enter the body. A menstrual product containing PFAS likely poses a more acute health risk than, for example, a jacket containing PFAS. Even if direct exposure to the product is limited, any PFAS in a product can, eventually, end up in the environment, including in drinking water.
As with enforcement, determining an appropriate concentration threshold could benefit from a public entity with scientists with health and environmental backgrounds determining the risks of chemical exposure at different levels. Without that resource, the Legislature is tasked with setting the appropriately protective standard in statute, and presumably updating those statutory thresholds by legislation when needed.
This bill prohibits intentionally added PFAS in menstrual products and commencing January 1, 2027, PFAS at or above 10 ppm, as measured in total organic fluorine. For the threshold set in this bill, the author’s office points to limits established by OEKO-TEX, an organization of 17 independent research and testing institutions in Europe and Japan that continually develops test methods and define limits for chemicals in textiles and leathers. OEKO-TEX’s ECO PASSPORT standard, which is an internationally-recognized certificate for textile and leather determined safe and environmentally friendly, disallow any intentionally added PFAS or any PFAS above 10 ppm as measured in extractable organic fluorine.
Concerns have been raised that the 10 ppm threshold is too low. These assert that unavoidable trace quantities of PFAS through the manufacturing processes could exceed this value and that detection methods down to concentrations as low as 10 ppm can be unreliable. Committee staff have not been provided with data demonstrating what concentrations may constitute technically unavoidable trace quantities. Commercial labs regularly test cosmetics for PFAS concentrations down to 10 ppm and research laboratories often test for concentrations lower as 1 ppm. Testing sensitivities have improved over time and the author indicates that an implementation date of 2027 leaves time for more accurate and reliable tests to become more widespread.
Other proposed and statutory PFAS bans have differing concentration thresholds in different product categories ranging from 1 ppm to 100 ppm, and some have this threshold decrease over time (see the “Related/Prior Legislation” section of this analysis). AB 727 (Weber), for example, would set a 10 ppm limit in cleaning products beginning in 2028, and AB 1423 (Schiavo) would set a 1 ppm limit for artificial turf beginning in 2024. For drinking water, which may deserve the most stringent concentration threshold, the US EPA’s proposed legally enforceable Maximum Contaminant Level (MCLs) is 4 parts per trillion (ppt) for PFOA and PFOS, two chemicals in the PFAS family considered separately due to their likely carcinogenicity (these are also on California’s Prop 65 list). In 2027, the same time the 10 ppm threshold of this bill would go into effect, certain textiles, including clothing, may not contain more than 50 ppm of PFAS under AB 1817 (Ting, 2022). Menstrual products generally have a higher risk of PFAS entering the body than most clothing articles.
Related/Prior Legislation
AB 727 (Weber) would prohibit, beginning January 1, 2026, a person from manufacturing, selling, delivering, distributing, holding, or offering for sale, a cleaning product that contains intentionally-added PFAS or PFAS at or above 50 ppm, on January 1, 2027, a cleaning product that contains PFAS at or above 25 ppm, and on January 1, 2028, at or above 10 ppm. This bill is pending before the Senate Environmental Quality Committee.
AB 1423 (Schiavo) would prohibit, commencing January 1, 2024, a public entity and certain educational institutions from purchasing or installing a covered surface that contains intentionally added PFAS or PFAS at a concentration at or above 1 ppm, and commencing January 1, 2025, would prohibit a person or entity from manufacturing, distributing, selling, or offering for sale in the state any covered surface that contains intentionally added PFAS or PFAS at a concentration at or above 1 ppm. This bill is pending before the Senate Environmental Quality Committee.
AB 347 (Ting) would require DTSC to enforce and ensure compliance with PFAS prohibitions and require DTSC to test at least 200 juvenile products and 200 food packaging samples by January 1, 2025. It would authorize DTSC to assess fines against manufacturers in violation of the PFAS prohibitions. This bill is pending before the Senate Environmental Quality Committee.
AB 1817 (Ting, Chapter 762, Statutes of 2022) prohibits, beginning January 1, 2024, a person from distributing, selling, or offering for sale in the state a textile article, as defined, that contains intentionally added PFAS, or starting January 1, 2025, any PFAS at concentrations of 100 ppm or more, or starting January 1, 2027, 50 ppm or more.
AB 2771 (Friedman, Chapter 804, Statutes of 2022) prohibits, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added PFAS.
AB 502 (Allen, Chapter 701, Statutes of 2022) makes a number of updates to California’s Safer Consumer Products Program in line with perceived shortcomings from its first ten years with regards to the speed of the program to filling existing data gaps.
AB 1200 (Ting, Chapter 503, Statutes of 2021) prohibits, commencing January 1, 2023, the sale of food packaging, as defined, that contains intentionally added PFAS or PFAS at concentrations at or above 100 ppm. This bill also requires, starting January 1, 2024, certain labels for cookware products containing intentionally added chemicals from specified lists.
AB 652 (Friedman, Chapter 500, Statutes of 2021) prohibits, on or after July 1, 2023, a person from selling or distributing in commerce any new juvenile products that contain intentionally added PFAS or PFAS at or above 100 ppm.
AB 2762 (Muratsuchi, Chapter 314, Statutes of 2020) prohibits, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale, in commerce any cosmetic product that contains any specified intentionally added ingredients, including some PFAS chemicals.
SB 1044 (Allen, Chapter 308, Statutes of 2020) prohibits the manufacture, sale, distribution, and use of firefighting foam containing intentionally added PFAS chemicals by January 1, 2022, with some exceptions, and requires notification of the presence of intentionally added PFAS in the protective equipment of firefighters.
DOUBLE REFERRAL:
If this measure is approved by the Senate Environmental Quality Committee, the do pass motion must include the action to re-refer the bill to the Senate Judiciary Committee.
SOURCE:
Author
SUPPORT:
American College of Obstetricians and Gynecologists District IX
Breast Cancer Prevention Partners
California Association of Sanitation Agencies
California Legislative Women's Caucus
California Professional Firefighters
California Water Service
Californians Against Waste
CALPRIG
Center for Public Environmental Oversight
City of Camarillo
Clean Seas Lobbying Coalition
Clean Water Action
Environmental Working Group
Green Science Policy Institute
Irvine Ranch Water District
Los Angeles County Sanitation Districts
National Stewardship Action Council
Natural Resources Defense Council (NRDC)
Republic Services - Western Region
Responsible Purchasing Network
San Diego County Water Authority
Sierra Club California
Weideman Group
Women's Voices for The Earth
OPPOSITION:
None received
ARGUMENTS IN SUPPORT:
According to a coalition of supporters, “We also support the threshold of 10 ppm PFAS as part of the definition of regulated PFAS. With the threshold, AB 246 is in line with other bills passed by this Legislature to ban PFAS in textiles, children’s products, and food packaging by defining regulated PFAS as PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product as well as the presence of PFAS in a product or product component at or above a specified threshold, as measured in total organic fluorine.
“Setting a robust threshold is especially important in AB 246 because it addresses the use of PFAS in products that are used within, or in close contact with sensitive parts of women’s bodies. Given that these chemicals are associated with reproductive harm, cancers, immune system interference and other serious health impacts, they have no business being used in such intimate personal care products. In addition, their use can contribute to water contamination when reusable products are washed or others are disposed of.”
-- END --
ASSEMBLY THIRD READING
ATR Bill Id:AB 246
Author:(Papan)
As Amended Ver:April 12, 2023
Majority vote
SUMMARY
Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances (PFAS).
Major Provisions
- Defines "regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS" as either of the following:
- PFAS that a manufacturer has intentionally added to a product and that has a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product; or,
- Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million (ppm), as measured in total organic fluorine.
- Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS.
- Requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this bill and does not contain any regulated PFAS.
- Provides that, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a person or entity that violates the PFAS restrictions of this bill shall be liable for a civil penalty not to exceed $5,000 for a first violation, and not to exceed $10,000 for each subsequent violation.
COMMENTS
Perfluoroalkyl and polyfluoroalkyl substances (PFAS): Per- and polyfluorinated substances (PFASs) are a large group of synthetic, highly fluorinated substances that have been widely used in industrial and consumer applications for their heat, water, and lipid resistance properties for more than seven decades. PFAS are long-lasting chemicals that break down very slowly over time. PFAS are ubiquitous, and researchers have found PFAS in indoor and outdoor environments, plants, soil, food, drinking water, wildlife, companion animals, production animals, and humans at locations across the nation and around the globe. Scientific studies have shown that exposure to some PFAS may be linked to harmful health effects in humans and animals. More than 9,000 PFAS chemicals are included in the United States Environmental Protection Agency's (US EPA's) Master List of PFAS Substances.
Exposure to PFAS: The main route of exposure to PFAS is through ingestion of contaminated food or liquid (accounting for up to half of total exposure), and through inhalation and ingestion of contaminated indoor air and dust. Food can become contaminated with PFAS through contaminated soil and water used to grow the food, food packaging containing PFAS, and equipment that uses PFAS during food processing. Some foods, such as fish, meat, eggs and leafy vegetables, may contain PFAS due to bioaccumulation and crop uptake. Studies have shown that PFAS can transfer from pregnant mothers to their fetuses via the placenta during gestation, as well as transfer from nursing mothers to their infants via breastfeeding. Dermal exposure is also possible when people touch products treated with PFAS, such as carpets or clothing. Young children may be susceptible to higher levels of exposure than adults because they ingest more dust containing PFAS and mouth PFAS-treated consumer products. Workers, such as carpet installers, carpet cleaners, firefighters, and workers in furniture, furnishings, outdoor clothing, and carpet stores, may also experience above average PFAS exposure levels.
Exposure to PFAS in drinking water is an escalating concern due to the persistence of PFAS chemicals in the environment and their tendency to accumulate in groundwater.
Hazard traits of PFAS: An intrinsic property of PFAS is the extreme environmental persistence of either the individual compounds or their degradation products or both, resulting in their classification as "forever chemicals." Most PFAS are mobile in environmental media such as air and water, and thus are widespread in living organisms and the environment. Several PFAS bioaccumulate significantly in animals or plants and emerging evidence points to their phytotoxicity, aquatic toxicity, and terrestrial ecotoxicity.
According to the US EPA, current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to: reproductive effects such as decreased fertility or increased high blood pressure in pregnant women; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body's immune system to fight infections, including reduced vaccine response; interference with the body's natural hormones; and, increased cholesterol levels and/or risk of obesity.
Regulating PFAS as a class: The Department of Toxic Substances Control (DTSC) has adopted a rationale for regulating PFAS chemicals as a class, concluding, "it is both ineffective and impractical to regulate this complex class of chemicals with a piecemeal approach." This rationale was presented in the February, 2021, Environmental Health Perspectives article, "Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program," which states, "The widespread use, large number, and diverse chemical structures of PFAS pose challenges to any sufficiently protective regulation, emissions reduction, and remediation at contaminated sites. Regulating only a subset of PFAS has led to their replacement with other members of the class with similar hazards, that is, regrettable substitutions… Regulating PFAS as a class is thus logical, necessary, and forward-thinking."
PFAS in menstrual products: In the United States, approximately 72.7 million women are of reproductive age (15 - 49). During the reproductive stage of their lives, people who menstruate rely on a diverse range of menstrual products, from tampons to pads to menstrual cups to period underwear. To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. Conducted at US EPA-certified laboratories between 2020 and 2022, the tests detected organic fluorine, a marker for PFAS, in several menstrual products. For example, 22% of the 23 tampon products tested had indications of PFAS, including two products advertised as "organic." Forty eight percent of 46 different sanitary pads, panty liners, and incontinence pads tested had indications of PFAS, including several products marketed as "organic" and "natural." Sixty-five percent of period underwear products tested, and 57% of the period underwear brands tested, had detectable levels of fluorine present. Exposure to PFAS through menstrual products is particularly concerning because the vagina is an extremely vascular area and dermal exposure in the vaginal area is often higher than other places of the body. Additionally, people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.
This bill: This bill prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS.
Enforcement: Like this bill, most of the state's chemical prohibition bills were placed in what is sometimes referred to as the "orphan codes." In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no compliance program, no guidance for manufacturers seeking to comply with these laws, no related information for consumers, and no state entity investigating complaints, testing products for compliance, or bringing enforcement actions against violators.
This bill: This bill provides the Attorney General (AG) and other government attorneys with specified civil penalties to bring against violators of the law. These penalty provisions are in addition to the AG's existing authority to enforce this, and related product safety statutory provisions, such as through the Unfair Competition Law. The author of this bill, Committee staff, and stakeholders are continuing to discuss the development of a more comprehensive enforcement program for laws regulating dangerous chemicals in consumer products.
According to the Author
"These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAS in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
AB 246 takes a critical step towards protecting women's health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California's pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women's health must be prioritized over the use of these unnecessary chemicals. It's past time to protect women and our environment."
Arguments in Support
The California Professional Firefighters argue, "AB 246 prohibits the sale and distribution of all menstrual products containing intentionally-added PFAS, including both disposable and reusable products. These health and sanitary items can lead to extended and frequent exposure to these toxic substances over many years of use, leading to decades' worth of unnecessary exposure when viable alternatives are available. In order to address this, manufacturers will be required to use the least toxic alternatives in their reformulation of their products, ensuring that all menstrual products sold and distributed in California are manufactured with the health and safety of their users as a priority… Firefighters face elevated levels of exposure to PFAS through a variety of means, including personal protective equipment (PPE) that is treated with PFAS for its water-resistant properties. Reducing exposure to PFAS wherever possible is critical for the health and safety of California’s fire service."
The California Association of Sanitation Agencies argues, "This is an important source control strategy for reducing PFAS contamination in wastewater systems and California's watersheds. Feminine hygiene products that contain PFAS have a direct pathway to wastewater when disposable products are erroneously flushed, or when reusable products are washed in household laundry systems."
Arguments in Opposition
The Center for Baby and Adult Hygiene Products (BAHP) argues, "We share the author's intent with AB246 to protect the health and safety of California consumers of menstrual products. However, the April 10th amendment including PFAS not intentionally added in instances where presence of the substance is measured at the low level of 10 parts per million poses serious compliance challenges. The product testing data for that low threshold is inherently unreliable under Total Organofluorine (TOF) testing and it can indicate fluorinated compounds that are not PFAS. If the Committee is intent on addressing some level of PFAS that is not intentionally added, aligning AB246 with the 2021 California law (AB652) addressing PFAS in juvenile products with respect to its 100ppm threshold is a reasonable approach."
FISCAL COMMENTS
According to the Assembly Appropriations Committee, the Department of Justice (DOJ) anticipates minor and absorbable costs as a result of enactment of this bill. The DOJ notes, however, that while enactment of individual chemical prohibition bills this session may result in no significant impact to the DOJ, should several of the current chemical prohibition bills with similar enforcement provisions become law, the DOJ would need to request additional resources to process the increase in its workload.
VOTES
ASM ENVIRONMENTAL SAFETY AND TOXIC MATERIALS: 8-0-1
YES: Lee, Hoover, Arambula, Bauer-Kahan, Connolly, McKinnor, Pacheco, Zbur
ABS, ABST OR NV: Ta
ASM APPROPRIATIONS: 14-0-2
YES: Holden, Bryan, Calderon, Wendy Carrillo, Dixon, Mike Fong, Hart, Lowenthal, Papan, Pellerin, Robert Rivas, Sanchez, Weber, Wilson
ABS, ABST OR NV: Megan Dahle, Mathis
UPDATED
VERSION: April 12, 2023
CONSULTANT: Shannon McKinney / E.S. & T.M. / (916) 319-3965 FN: 0000313
Date of Hearing: May 3, 2023
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Chris Holden, Chair
ABPCA Bill Id:AB 246
Author:(Papan) – As Amended Ver:April 12, 2023
Policy Committee: | Environmental Safety and Toxic Materials | Vote: | 8 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill prohibits the sale of menstrual products that contain regulated perfluoroalkyl and polyfluoroalkyl substances (PFAS).
Specifically, this bill, among other things:
- Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS.
- Requires a manufacturer to use the least toxic alternative, including alternative design, when removing regulated PFAS in menstrual products to comply with the restrictions in this bill.
- Requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating the menstrual product is in compliance with the requirements of this bill and does not contain any regulated PFAS.
- Provides that a distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of the prohibitions in this bill if they relied in good faith on the certificate of compliance provided by the manufacturer.
- Provides that, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a person or entity that violates the restrictions of this bill shall be liable for a civil penalty not to exceed $5,000 for a first violation, and not to exceed $10,000 for each subsequent violation.
- Provides that these penalty provisions do not impair or impede any other rights, causes of action, claims, or defenses available under any other law, and that the remedies provided in this bill are cumulative with any other remedies available under any other law.
FISCAL EFFECT:
The Department of Justice (DOJ) anticipates minor and absorbable costs as a result of this bill but notes as numerous bills this session may result in no significant impact to DOJ, should an aggregate of these bills become law, DOJ would need to request additional resources to process the increase to its workload.
COMMENTS:
1) Purpose. According to the author:
The presence of PFAs in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. AB 246 takes a critical step towards protecting women’s health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California’s pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products.
2) Background. PFAS are a ubiquitous class of more than 9,000 synthetic chemicals that have been in use in a wide range of industrial and consumer products since the 1940s for their heat, water, and lipid resistance properties. PFAS are linked to a variety of health harms, such as cancer, endocrine disruption, developmental and reproductive toxicity, and immune dysregulation. These chemicals are harmful at extremely low doses; contaminate the air, soil, drinking water, plants and wildlife during production, use and disposal; and are extremely persistent in the environment. In fact, PFAS are commonly referred to as “forever chemicals” because they do not break down and instead bioaccumulate and persist in human and animal tissues.
Several state agencies, including the Department of Toxic Substances Control, the State Water Board, and the Office of Environmental Health Hazard Assessment, have undertaken efforts to address PFAS. The Legislature has also enacted bans on PFAS in textiles, food packaging, juvenile products, certain cosmetics, and firefighting foam; authorized the State Water Board to order public water systems to monitor for PFAS; and required municipalities to notify customers for PFAS detected above notification levels. Many studies have shown that PFAS are prevalent in menstrual products, including in products advertised as “organic” and “natural”. The author cites a recent study, which found that 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons.
Enforcement. Like this bill, most of the state’s chemical prohibition bills are placed in what is sometimes referred to as the "orphan codes." In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no compliance program, no guidance for manufacturers seeking to comply with these laws, no related information for consumers, and no state entity investigating complaints, testing products for compliance, or bringing enforcement actions against violators. This bill and the bills listed under “related legislation” include provisions that provide the Attorney General (AG) and local government attorneys with specified civil penalties to bring against violators of the law. These penalty provisions are in addition to the AG’s existing authority to enforce this and related product safety bills, such as through the Unfair Competition Law (UCL), although this committee and the policy committee are not aware of any enforcement actions taken by the AG or a district attorney under the UCL, or any other law, to enforce the chemical prohibition laws under the "orphan codes." The authors of these bills, committee staff, and stakeholders are continuing to discuss what a more comprehensive enforcement program might look like for laws regulating dangerous chemicals in consumer products.
3) Related Legislation. AB 418 (Gabriel) prohibits, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, distributing, holding, or offering for sale, in commerce a food product that contains any of several specified substances. AB 418 is pending in this committee.
AB 727 (Weber) prohibits, beginning January 1, 2025, a person from manufacturing, selling, delivering, distributing, holding, or offering for sale, a cleaning product that contains intentionally added PFAS or PFAS at or above 50 parts per million (PPM), and on January 1, 2027, a cleaning product that contains PFAS at or above 25 PPM. AB 727 is pending in this committee.
AB 1423 (Schiavo) prohibits, commencing January 1, 2025, the manufacturing or sale of artificial turf that contains PFAS, and, commencing January 1, 2024, a public entity, a public or private school, or a public or private institution of higher learning, from purchasing or installing artificial turf that contains PFAS. AB 1423 is pending in this committee.
Analysis Prepared by: Nikita Koraddi / APPR. / (916) 319-2081
Date of Hearing: April 18, 2023
ASSEMBLY COMMITTEE ON ENVIRONMENTAL SAFETY AND TOXIC MATERIALS
Alex Lee, Chair
ABPCA Bill Id:AB 246 (
Author:Papan) – As Amended Ver:April 12, 2023
SUBJECT: Product safety: menstrual products: perfluoroalkyl and polyfluoroalkyl substances
SUMMARY: Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS. Specifically, this bill:
- Defines "menstrual product" as a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
- Defines "perfluoroalkyl and polyfluoroalkyl substances" or "PFAS" as a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
- Defines "regulated perfluoroalkyl and polyfluoroalkyl substances or PFAS" as either of the following:
- PFAS that a manufacturer has intentionally added to a product and that has a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product; or,
- Commencing January 1, 2027, the presence of PFAS in a product or product component at or above 10 parts per million (ppm), as measured in total organic fluorine.
- Prohibits, commencing January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any menstrual products that contain regulated PFAS.
- Requires a manufacturer to use the least toxic alternative, including alternative design, when removing regulated PFAS in menstrual products to comply with the restrictions in this bill.
- Requires a manufacturer of a menstrual product to provide persons that offer the product for sale or distribution in the state with a certificate of compliance stating that the menstrual product is in compliance with the requirements of this bill and does not contain any regulated PFAS.
- Requires a certificate of compliance provided pursuant to this bill to be signed by an authorized official of the manufacturer. Authorizes the certificate of compliance to be provided electronically.
- Provides that a distributor or retailer of a menstrual product, if they are not also the manufacturer of the product, shall not be held in violation of the prohibitions in this bill if they relied in good faith on the certificate of compliance provided by the manufacturer.
- Provides that, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a person or entity that violates the PFAS restrictions of this bill shall be liable for a civil penalty not to exceed five thousand dollars ($5,000) for a first violation, and not to exceed ten thousand dollars ($10,000) for each subsequent violation.
- Provides that these penalty provisions do not impair or impede any other rights, causes of action, claims, or defenses available under any other law. Provides that the remedies delineated in the bill are cumulative with any other remedies available under any other law.
EXISTING LAW:
- Requires, commencing January 1, 2022, a person that sells firefighter personal protective equipment to provide a written notice to the purchaser if the firefighter personal protective equipment contains intentionally added PFAS chemicals. (Health and Safety Code (HSC) § 13029 (b)(1))
- Prohibits, commencing January 1, 2022, a manufacturer of class B firefighting foam from manufacturing, or knowingly selling, offering for sale, distributing for sale, or distributing for use, and a person from using, class B firefighting foam containing intentionally added PFAS chemicals. (HSC § 13061 (b)(1))
- Prohibits, on and after July 1, 2023, a person, including, but not limited to, a manufacturer, from selling or distributing in commerce in this state any new, not previously owned, juvenile product, as defined, that contains intentionally added PFAS or PFAS at or above 100 ppm, as measured in total organic fluorine. (HSC § 108946)
- Prohibits, on or after January 1, 2025, a person from manufacturing, distributing, selling, or offering for sale in the state any new, not previously used, textile articles that contain intentionally added PFAS, or PFAS at or above 100 PPM, and on or after January 1, 2027, 50 PPM, as measured in total organic fluorine. (HSC § 108971)
- Prohibits, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale, in commerce any cosmetic product that contains any specified intentionally added ingredients, including some PFAS chemicals. (HSC § 108980 (a))
- Prohibits, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added PFAS. (HSC § 108981.5)
- Prohibits, commencing on January 1, 2023, a person from distributing, selling, or offering for sale in the state any food packaging that contains that contains intentionally added PFAS or PFAS at or above 100 ppm, as measured in total organic fluorine. (HSC § 109000)
- Authorizes the State Water Resources Control Board (State Water Board) to order a public water system to monitor for PFAS; requires community water systems to report detections; and, where a detected level of these substances exceeds the response level, to take a water source out of use or provide a prescribed public notification. (HSC §116378)
Under the California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65):
- Prohibits a person, in the course of doing business, from knowingly discharging or releasing a chemical known to the state to cause cancer or reproductive toxicity into water or onto or into land where such chemical passes or probably will pass into any source of drinking water. (HSC § 25249.5)
- Prohibits a person, in the course of doing business, from knowingly and intentionally exposing any individual to a chemical known to the state to cause cancer or reproductive toxicity without first giving clear and reasonable warning to such individual. (HSC § 25249.6)
- Requires the Governor to publish a list of chemicals known to cause cancer or reproductive toxicity and to annually revise the list. The Office of Environmental Health Hazard Assessment (OEHHA) has listed perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), which are members of the PFAS class, as chemicals known to the state to cause developmental toxicity. (HSC § 25249.8)
Under the Safer Consumer Products (Green Chemistry) statutes:
- Requires the Department of Toxic Substances Control (DTSC) to adopt regulations to establish a process to identify and prioritize chemicals or chemical ingredients in consumer products that may be considered chemicals of concern, as specified. (HSC § 25252)
- Requires DTSC to adopt regulations to establish a process to evaluate chemicals of concern in consumer products, and their potential alternatives, to determine how to best limit exposure or to reduce the level of hazard posed by a chemical of concern. (HSC § 25253 (a))
- Specifies, but does not limit, regulatory responses that DTSC can take following the completion of an alternatives analysis, ranging from no action, to a prohibition of the chemical in the product. (HSC § 25253)
FISCAL EFFECT: Unknown.
COMMENTS:
Need for the bill: According to the author, "These once ubiquitous, forever compounds have been linked to health problems, including breast and other cancers, hormone disruption, kidney and liver damage, thyroid disease, developmental harm, and immune system disruption. The presence of PFAs in menstrual products contributes to existing to gender health inequities as exposure to PFAS is almost unavoidable. In a recent study, 48% of sanitary pads, incontinence pads, and panty liners tested were found to contain PFAS, as were 22% of tampons. Additionally, menstrual products have shown higher levels of PFAS than the levels found in tap water.
AB 246 takes a critical step towards protecting women’s health and reducing the amount of PFAS in the environment by eliminating polyfluoroalkyl substances (PFAS) from menstrual products. California’s pursuit for gender equity and clean drinking waters requires action to ensure that feminine hygiene products are safe, clean and free from forever chemicals. With viable alternatives available, there is no longer a good rationale for their use in menstrual products. Women’s health must be prioritized over the use of these unnecessary chemicals. It’s past time to protect women and our environment."
Perfluoroalkyl and polyfluoroalkyl substances (PFAS): Per- and polyfluorinated substances (PFASs) are a large group of synthetic, highly fluorinated substances that have been widely used in industrial and consumer applications for their heat, water, and lipid resistance properties for more than seven decades. PFAS are long-lasting chemicals that break down very slowly over time. PFAS are ubiquitous, and researchers have found PFAS in indoor and outdoor environments, plants, soil, food, drinking water, wildlife, companion animals, production animals, and humans at locations across the nation and around the globe. Scientific studies have shown that exposure to some PFAS may be linked to harmful health effects in humans and animals. More than 9,000 PFAS chemicals are included in the United States Environmental Protection Agency's (US EPA's) Master List of PFAS Substances. The persistence and proliferation of PFAS chemicals makes it challenging to study and assess the overall potential human health and environmental risks of PFAS exposure.
The breadth of uses of PFAS is immense, making it nearly impossible to avoid exposure. PFAS are used extensively in surface coating and protectant formulations due to their unique ability to reduce the surface tension of liquids. In consumer products, PFAS is used in carpets, furniture fabrics, apparel, paper packaging for food, non-stick cookware, personal care products, and other products designed to be waterproof; grease, heat, water and stain resistant; or, non-stick. Commercial applications span many sectors of the economy, including aerospace, apparel, automotive, building and construction, pharmaceuticals, medical devices, paints, electronics, semiconductors, energy, oil and gas exploration, first responder safety, firefighting foams, and health care. During production, use, and disposal, PFAS can migrate into the soil, water, and air.
Exposure to PFAS: The main route of exposure to PFAS is through ingestion of contaminated food or liquid (accounting for up to half of total exposure), and through inhalation and ingestion of contaminated indoor air and dust. Food can become contaminated with PFAS through contaminated soil and water used to grow the food, food packaging containing PFAS, and equipment that uses PFAS during food processing. Some foods, such as fish, meat, eggs and leafy vegetables, may contain PFAS due to bioaccumulation and crop uptake. Studies have shown that PFAS can transfer from pregnant mothers to their fetuses via the placenta during gestation, as well as transfer from nursing mothers to their infants via breastfeeding. Dermal exposure is also possible when people touch products treated with PFAS, such as carpets or clothing. Young children may be susceptible to higher levels of exposure than adults because they ingest more dust containing PFAS and mouth PFAS-treated consumer products. Workers, such as carpet installers, carpet cleaners, firefighters, and workers in furniture, furnishings, outdoor clothing, and carpet stores, may also experience above average PFAS exposure levels.
Exposure to PFAS in drinking water is an escalating concern due to the persistence of PFAS chemicals in the environment and their tendency to accumulate in groundwater. Groundwater PFAS contamination typically has been associated with industrial facilities where these chemicals were manufactured or used in other products, and in airfields where the chemicals have been used for firefighting. PFAS chemicals can also enter the environment and drinking water through composting, landfilling, recycling, and incineration of products containing PFAS. The State Water Board indicates that the four major sources of PFAS in drinking water in California are fire training/fire response sites, industrial sites, landfills, and wastewater treatment plants/biosolids. The State Water Board notes that because of their presence and persistence in many drinking water supplies, PFAS remain a serious source of exposure decades after their release into the environment.
Like humans, wildlife is exposed to PFAS by consuming contaminated water or food. Within aquatic food webs, PFAS were found to increase in concentration from ambient water to plankton and further up the food chain.
Hazard traits of PFAS: According to DTSC, all PFAS display at least one of the hazard traits identified in California's Safer Consumer Products (Green Chemistry) Hazard Traits Regulations (22 C.C.R § 69401 et seq.). An intrinsic property of PFAS is the extreme environmental persistence of either the individual compounds or their degradation products or both, resulting in their classification as "forever chemicals." Most PFAS are mobile in environmental media such as air and water, and thus are widespread in living organisms and the environment. Several PFAS bioaccumulate significantly in animals or plants and emerging evidence points to their phytotoxicity, aquatic toxicity, and terrestrial ecotoxicity.
DTSC contends that exposure to PFAS can lead to adverse health outcomes in humans. If humans are exposed to PFAS through diet, drinking water, or inhalation, some of these chemicals remain in the body for a long time. As people continue to be exposed to PFAS, the PFAS levels in their bodies may increase to the point that they suffer adverse health effects. According to the US EPA, current peer-reviewed scientific studies have shown that exposure to certain levels of PFAS may lead to: reproductive effects such as decreased fertility or increased high blood pressure in pregnant women; developmental effects or delays in children, including low birth weight, accelerated puberty, bone variations, or behavioral changes; increased risk of some cancers, including prostate, kidney, and testicular cancers; reduced ability of the body’s immune system to fight infections, including reduced vaccine response; interference with the body’s natural hormones; and, increased cholesterol levels and/or risk of obesity.
Regulating PFAS as a class: DTSC has adopted a rationale for regulating PFAS chemicals as a class, concluding, "it is both ineffective and impractical to regulate this complex class of chemicals with a piecemeal approach." This rationale was presented in the February, 2021, Environmental Health Perspectives article, "Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program." The authors of the article state,
"The widespread use, large number, and diverse chemical structures of PFAS pose challenges to any sufficiently protective regulation, emissions reduction, and remediation at contaminated sites. Regulating only a subset of PFAS has led to their replacement with other members of the class with similar hazards, that is, regrettable substitutions. Regulations that focus solely on perfluoroalkyl acids (PFAAs) are ineffective, given that nearly all other PFAS can generate PFAAs in the environment… We at the California DTSC propose regulating certain consumer products if they contain any member of the class of PFAS because: a) all PFAS, or their degradation, reaction, or metabolism products, display at least one common hazard trait according to the California Code of Regulations, namely environmental persistence; and b) certain key PFAS that are the degradation, reaction or metabolism products, or impurities of nearly all other PFAS display additional hazard traits, including toxicity; are widespread in the environment, humans, and biota; and will continue to cause adverse impacts for as long as any PFAS continue to be used. Regulating PFAS as a class is thus logical, necessary, and forward-thinking."
Other researchers have made the case for managing PFAS as a chemical class, including in "Scientific Basis for Managing PFAS as a Chemical Class" published in June, 2020, in Environmental Science & Technology Letters and "Strategies for grouping per- and polyfluoroalkyl substances (PFAS) to protect human and environmental health," also published in June, 2020, in Environmental Science: Processes & Impacts.
PFAS in menstrual products: In the United States, approximately 72.7 million women are of reproductive age (15-49). During the reproductive stage of their lives, people who menstruate rely on a diverse range of menstrual products, from tampons to pads to menstrual cups to period underwear. To illustrate the prevalence of PFAS in menstrual products, the author of the bill points to tests on menstrual products commissioned by the consumer watchdog site, Mamavation, and Environmental Health News. Conducted at US EPA-certified laboratories between 2020 and 2022, the tests detected organic fluorine, a marker for PFAS, in several menstrual products. For example, 22% of the 23 tampon products tested had indications of PFAS, including 2 products advertised as "organic." Forty eight percent of 46 different sanitary pads, panty liners, and incontinence pads tested had indications of PFAS, including several products marketed as "organic" and "natural." Additional tests by these two organizations found that 65% of period underwear products tested, and 57% of the period underwear brands tested, had detectable levels of fluorine present. Exposure to PFAS through menstrual products is particularly concerning because the vagina is an extremely vascular area and dermal exposure in the vaginal area is often higher than other places of the body. Additionally, people using menstrual products are of reproductive age, thus exposure could potentially impact unborn children as well as the person using the product.
Recent US EPA action on PFAS: According to the US EPA, "Under the Biden-Harris Administration, [US] EPA has restored scientific integrity and accelerated the pace of research and actions needed to tackle the PFAS crisis and protect American communities." On October 18, 2021, US EPA Administrator Michael S. Regan announced the agency’s PFAS Strategic Roadmap, which laid out a whole-of-agency approach to addressing PFAS. The roadmap sets timelines by which US EPA plans to take specific actions and commits to, "bolder new policies to safeguard public health, protect the environment, and hold polluters accountable."
Additionally, the US EPA reported that since the roadmap’s release in October 2021, US EPA has taken a number of key actions to address PFAS, including it proposed to designate two PFAS as hazardous substances under the federal Comprehensive Environmental Response, Compensation, and Liability Act; released drinking water health advisories for four PFAS; laid the foundation for enhancing data on PFAS; and, began distributing $10 billion in funding to address emerging contaminants under the Bipartisan Infrastructure Law.
State action on PFAS: California has undertaken efforts to address PFAS substances across several state entities.
At DTSC, all PFAS chemicals are "Candidate Chemicals" under the Safer Consumer Products (SCP, previously known as Green Chemistry) Program, because they exhibit a hazard trait and/or an environmental or toxicological endpoint, and the entire class of PFAS was added by the California Environmental Contaminant Biomonitoring Program to its list of priority chemicals.
On July 1, 2021, DTSC designated carpets and rugs containing PFAS as a "Priority Product." A Priority Product is a consumer product identified by DTSC that contains one or more Candidate Chemicals and that has the potential to contribute to significant or widespread adverse impacts to humans or the environment. The Priority Product designation required domestic and foreign carpet and rug manufacturers that use PFAS and related chemicals in their products to submit information on all of the manufacturer’s products that contain PFAS and are sold in California, by August 30, 2021. Manufacturers were then required to show intent to remove or replace PFAS in their products, remove the product from the market, or identify potential alternatives to PFAS to be used in the product by December 28, 2021.
In regulations that went into effect on April 1, 2022, DTSC also designated treatments containing PFAS for use on converted textiles or leathers such as carpets, upholstery, clothing, and shoes as a Priority Product. Domestic and foreign manufacturers of treatments for converted textiles or leathers that contain any member of the class of PFAS selling their products in California were required to submit information on those products by May 31, 2022. After submitting the required information, manufacturers were then required to show intent to mitigate exposure to PFAS in their products by September 28, 2022.
DTSC has also proposed evaluating artificial turf with PFAS in their Draft Priority Product Work Plan for 2021-2023. Previously, DTSC proposed investigating PFAS in other product categories, such as food packaging and children’s products, but during the investigative period the Legislature prohibited PFAS in those product categories and it appears DTSC has shifted its resources to investigating other product/ chemical combinations.
OEHHA, under the Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65), listed PFOA and PFOS as chemicals known to the state to cause reproductive toxicity. In July, 2021, OEHHA announced the release of a draft document for public review describing proposed Public Health Goals (PHGs) for PFOA and PFOS in drinking water. A PHG is the level of a chemical contaminant in drinking water that does not pose a significant risk to health. PHGs published by OEHHA are considered by the State Water Resources Control Board (State Water Board) in setting drinking water regulatory standards (Maximum Contaminant Levels, or MCLs) for California.
The State Water Board has taken a number of additional recent actions related to PFAS in drinking water, including, in July 2020, issuing investigative orders to publicly owned treatment works that receive PFAS in their influent wastewater flow to include sampling for 31 PFAS compounds. In August 2020, it also issued a General Order for public water systems to sample for and report PFAS. It also issued drinking water notification levels and response levels for several PFAS compounds.
Recently, the State Legislature has taken action on PFAS by enacting a slew of bills prohibiting PFAS at different levels across many product categories. These include a ban on textiles that contain PFAS (AB 1817,Ting, Chapter 762, Statutes of 2022); a ban on cosmetic products that contain PFAS (AB 2771, Friedman, Chapter 804, Statutes of 2022); a ban on food packaging that contains PFAS (AB 1200, Ting, Chapter 503, Statutes of 2021); a ban on new juvenile products that contain PFAS (AB 652, Freidman, Chapter 500, Statutes of 2021); and, a ban on firefighting foam containing PFAS (SB 1044, Allen, Chapter 308, Statutes of 2020). The Legislature also authorized the State Water Board to order public water systems to monitor for PFAS and required municipalities to notify consumers for PFAS detected above notification levels (AB 756, C. Garcia, Chapter 162, Statutes of 2019).
Chemical bans and the Safer Consumer Products Program: In 2008, California enacted AB 1879 (Feuer and Huffman, Chapter 559, Statutes of 2008) to establish a regulatory process for identifying and prioritizing chemicals of concern in consumer products, to create methods for analyzing alternatives to existing hazardous chemicals, and to ultimately take regulatory action to reduce the level of harm from the chemicals in those products. DTSC did this by promulgating the Safer Consumer Products regulations, which took effect in October 2013. DTSC's approach provides science-based criteria and procedures for identifying and evaluating alternatives with the objective of replacing chemicals of concern with safer chemicals and avoiding the use of substitute chemicals that pose equal or greater harm.
While the intent of AB 1879 is to establish a robust and thorough regulatory process rooted in science to consider exposure to chemicals in consumer products, it has long been recognized that DTSC does not have the resources to evaluate all, or even a significant percentage of, chemicals in every consumer product application. The permutations of product and chemical combinations are virtually limitless. To that end, the Safer Consumer Products statute does not preclude the Legislature from taking legislative action on the use of chemicals in consumer product applications. When there is credible scientific evidence to support a change in state policy to protect public health, the Legislature can respond to that science more expeditiously than can DTSC. Since AB 1879 was enacted, the Legislature has enacted policies on various chemical-product applications, which include, in addition to the PFAS prohibitions listed above, a ban on flame retardants in children's products, mattresses, and upholstered furniture (AB 2998, Bloom, Chapter 924, Statutes of 2018); a ban on BPA in toddler sippy cups and bottles (AB 1319, Butler, Chapter 467, Statutes of 2011); a ban on the sale of jewelry with cadmium at certain levels (AB 929, Pavley, Chapter 313, Statutes of 2010); and, a ban on the sale of brake pads containing copper in exceedances of certain levels (SB 346, Kehoe, Chapter 307, Statutes of 2010).
DTSC, in fact, wrote in support of AB 1319 (Butler) stating: "DTSC does not believe that the [Safer Consumer Products] regulations should ever be viewed as excluding action that the Legislature might take to address specific product related concerns that are brought to its attention. Not only have the regulations taken longer to adopt than originally anticipated, DTSC also expects that the process to be represented in the regulations will be subject to time and resource constraints. There may be circumstances that warrant more timely action than DTSC can accommodate through its process."
Enforcement and compliance for chemical prohibition laws: Most of the chemical prohibition bills listed previously are placed in a unique location in the California Codes, sometimes referred to as the "orphan codes." In these code sections, no state agency is designated to provide oversight of the provisions of the law. As a result, there is no direct enforcement, no compliance program, no guidance for manufacturers seeking to comply with these laws, and no related information for consumers. This means there are no regulations or public guidance documents clarifying the intent of the law and no state entity investigating complaints, testing affected products for compliance, or bringing enforcement actions against violators. Because of these deficiencies, it is challenging for some manufacturers to comply and difficult or impossible to know if any manufacturers are complying with the requirements of the law.
This bill: The provisions of this bill are placed in the "orphan code" section of the Health and Safety Code.
Unfair Competition Law (UCL): The only current option for enforcement of the prohibitions in the "orphan codes" is for a district attorney or the state Attorney General to bring an action against a manufacturer under the UCL (unless specified otherwise). The UCL is one of the primary tools currently available to government attorneys to protect the public from "any unlawful, unfair or fraudulent business act or practice and unfair, deceptive, untrue or misleading advertising[.]" (Business and Professions Code Section 17200.). As recently summarized by the California Supreme Court:
The statute’s purpose is to protect both consumers and competitors by promoting fair competition in commercial markets for goods and services. In service of that purpose, the Legislature framed the UCL’s substantive provisions in broad, sweeping language to reach anything that can properly be called a business practice and that at the same time is forbidden by law. By proscribing any unlawful business practice, section 17200 borrows violations of other laws and treats them as unlawful practices that the unfair competition law makes independently actionable. [T]he Legislature…intended by this sweeping language to permit tribunals to enjoin on-going wrongful business conduct in whatever context such activity might occur. To that end, the Legislature has created a scheme of overlapping enforcement authority. […] While the UCL provides for both public and private enforcement, authorized public prosecutors have an additional tool to enforce the state's consumer protection laws: civil penalties. (Abbott Laboratories v. Superior Court (2020) 9 Cal. 5th 642, 651-52 [internal citations and quotations omitted.])
Remedies under the UCL include injunctive relief, restitution, and civil penalties. It is important to note that even though a district attorney or the Attorney General can take an action to enforce these chemical prohibitions in the "orphan codes" using the UCL, before a case is filed, a member of the public must purchase and test products at a certified laboratory for the prohibited chemical, which is expensive. Then, the Attorney General or district attorney must have the resources and ability to prioritize action on these complaints before other responsibilities.
To date, the Committee is unaware of any comprehensive report or investigation by any entity on compliance with the chemical prohibitions in the "orphan code," nor is it aware of any entity that is sampling, testing, or tracking compliance with the "orphan codes." Additionally, to date, the Committee is not aware of any enforcement actions taken by the Attorney General or a district attorney under the UCL, or any other law, to enforce any of the chemical prohibition laws under the "orphan codes."
This bill: While the provisions of this bill are placed under the "orphan" section of the Health and Safety Code, the author has added provisions that provide government attorneys with civil penalty options to bring against violators of the law. Specifically, this bill provides that, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney, a person or entity that violates the PFAS restrictions for menstrual products as delineated in this bill shall be liable for a civil penalty, capped at $5,000 for a first violation and $10,000 for each subsequent violation. The bill additionally provides that these penalty provisions do not impair or impede any other rights, causes of action, claims, or defenses available under any other law. AB 246 also provides that the remedies delineated in the bill are cumulative with any other remedies available under any other law. These penalty provisions are in addition to the authority to enforce under the UCL, and are consistent with existing statutory penalties relating to PFAS in firefighting foam.
In addition to the penalty provisions currently included in the bill, the author has indicated that she is willing to continue to work with the Committee and stakeholders on a comprehensive enforcement program for dangerous chemicals in products.
Acceptable levels of exposure to PFAS: This bill prohibits, in menstrual products, intentionally added PFAS, and commencing January 1, 2027, PFAS at or above 10 ppm, as measured in total organic fluorine. There are two other bills pending before the Committee with differing PFAS thresholds in different product categories, and 5 statutes with differing PFAS thresholds for other products (see the "Existing Law" section of this analysis.) As with enforcement, setting thresholds on chemicals in products would benefit from a public entity with oversight responsibility. In that case, a team of scientists with related public health backgrounds could set the appropriately protective thresholds and be able to update the thresholds through regulation consistent with emerging science. Without that resource, the Legislature is tasked with setting the appropriately protective standard in statute, and presumably updating those statutory thresholds by legislation when needed.
This bill: For the thresholds set in this bill, the author’s office points to OEKO-TEX ECO PASSPORT standards for textile and leather chemicals, which designates 10 ppm as the threshold value that indicates no intentional use.
Regrettable substitutions: While each of the laws listed in the "orphan code" prohibit a chemical that has been suspected of or found to be toxic or hazardous the laws do not prevent a manufacturer from replacing the prohibited chemical with another hazardous chemical, or a chemical even more hazardous than the one prohibited. In addition, several of the laws dealing with chemicals in the "orphan code" require manufacturers to use the least toxic alternative when replacing the chemical in question. Without a state entity overseeing these substitutions, it is difficult to know whether manufacturers are replacing prohibited chemicals with substances that are safer or more hazardous.
This bill: This bill requires a manufacturer to use the least toxic alternative, including alternative design, when removing regulated PFAS in menstrual products to comply with the restrictions in this bill.
Moving forward: This bill, along with the other PFAS bills pending in front of the Committee, takes a step forward on statutory chemical prohibitions by adding civil penalties for violations of the restrictions in the bill. However, there remains no entity proving guidance or ensuring compliance with the prohibitions. Moving forward, the authors of these bills, along with stakeholders, the Committee, and the Administration, should continue to discuss effective oversight of these new and existing chemical prohibition laws.
Related legislation:
- AB 727 (Weber). Prohibits, beginning January 1, 2025, a person from manufacturing, selling, delivering, distributing, holding, or offering for sale, a cleaning product that contains intentionally-added PFAS or PFAS at or above 50 PPM, and on January 1, 2027, a cleaning product that contains PFAS at or above 25 PPM. This bill is pending before the Assembly Environmental Safety and Toxic Materials Committee.
- AB 1423 (Schiavo). Prohibits, commencing January 1, 2025, a person or entity from manufacturing, distributing, selling, or offering for sale in the state any covered surface that contains PFAS, as defined, and prohibits, commencing January 1, 2024, a public entity, a public or private school, or a public or private institution of higher learning, as specified, from purchasing or installing a covered surface that contains PFAS. This bill is pending before the Assembly Environmental Safety and Toxic Materials Committee.
- AB 1817 (Ting, Chapter 762, Statutes of 2022). Prohibits, beginning January 1, 2024, a person from distributing, selling, or offering for sale in the state a textile article, as defined, that contains regulated PFAS, and requires a manufacturer to use the least toxic alternative when removing regulated PFAS in textile articles to comply with the provisions of the bill.
- AB 2771 (Friedman, Chapter 804, Statutes of 2022). Prohibits, commencing January 1, 2025, a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains intentionally added PFAS.
- AB 1200 (Ting, Chapter 503, Statutes of 2021). Prohibits, commencing January 1, 2023, the sale of food packaging that contains PFAS; requires, commencing January 1, 2024, cookware manufacturers to label their product if it contains an intentionally added chemical on specified lists; and prohibits, commencing January 1, 2023, for the internet and January 1, 2024, for the cookware package, a cookware manufacturer from making a claim that cookware is free of a chemical, unless no chemical from that chemical class is intentionally added to the cookware.
- AB 652 (Freidman, Chapter 500, Statutes of 2021). Prohibits, on or after July 1, 2023, a person from selling or distributing in commerce any new juvenile products that contain PFAS.
- SB 1044 (Allen, Chapter 308, Statutes of 2020). Prohibits the manufacture, sale, distribution, and use of firefighting foam containing PFAS chemicals by January 1, 2022, with some exceptions, and requires notification of the presence of PFAS in the protective equipment of firefighters.
- SB 1056 (Portantino, 2020). Would have required the State Water Board to establish an analytical laboratory method that can be used as a tool to assess the extent of PFAS contamination in drinking water, surface water, groundwater, and wastewater. This bill was held in the Senate Environmental Quality Committee.
- AB 1989 (C. Garcia, Chapter 272, Statutes of 2020). Requires a package or box containing menstrual products that was manufactured on or after January 1, 2023, for sale or distribution in this state to have printed on the label a plain and conspicuous list of all ingredients, as defined, in the product, by weight. Requires the same information to be posted on an internet website, as specified.
- AB 756 (C. Garcia, Chapter 162, Statutes of 2019). Authorizes the State Water Board to order one or more public water systems to monitor for PFAS and requires municipalities to notify consumers for PFAS detected above notification levels.
- AB 841 (Ting, Chapter 372, Statutes of 2019). As heard by the Assembly, would have required OEHHA to assess PFAS substances, especially as they might be found in drinking water, to determine which might pose a potential risk to human health. The contents of this bill were deleted in the Senate and amended with unrelated content.
- AB 958 (Ting, 2018). Would have required a manufacturer of food packaging or cookware sold in the state to visibly disclose on an exterior location of the food packaging or cookware packaging a specified statement relating to the presence of PFAS in the product. This bill was held on the Senate Floor.
- SB 1313 (Corbett, 2008). Would have prohibited the manufacture, sale, or distribution of any food contact substance, as defined, which contains perfluorinated compounds, as defined, in any concentration exceeding 10 parts per billion. This bill was vetoed by Governor Arnold Schwarzenegger whose veto message said, "I have signed AB 1879 (Feuer) and SB 509 (Simitian) which mark the beginning of California's historic Green Chemistry Initiative. It is within this process that chemicals like PFCs should be addressed."
REGISTERED SUPPORT / OPPOSITION:
Support
California Association of Sanitation Agencies
California Legislative Women's Caucus
California Professional Firefighters
Los Angeles County Sanitation Districts
NARAL Pro-Choice California
Silicon Valley Youth Climate Action
Opposition
None on file.
Analysis Prepared by: Shannon McKinney / E.S. & T.M. /
Discussed in Hearing
Assembly Floor
Senate Floor
Senate Standing Committee on Judiciary
Senate Standing Committee on Environmental Quality
Assembly Floor
Assembly Standing Committee on Environmental Safety and Toxic Materials
Bill Author
Bill Co-Author(s):